https://www.iconplc.com/ 2026-03-27T07:25:00+00:00 daily 1.0 https://www.iconplc.com/insights/blog/2016/07/13/under-new-medical-device 2024-05-02T13:44:12+01:00 0.5 https://www.iconplc.com/insights/blog/2018/04/13/brexit-uk-economic-operators-and-notified-bodies 2026-02-18T18:14:56+00:00 0.5 https://www.iconplc.com/insights/blog/2018/04/13/key-performance-indicators-and-governance 2024-04-18T12:44:33+01:00 0.5 https://www.iconplc.com/insights/blog/2018/04/13/managing-medical-device-cybersecurity-risks 2026-03-24T11:19:48+00:00 0.5 https://www.iconplc.com/insights/blog/2018/04/13/scaling-up-car-t-therapies 2026-01-23T14:54:00+00:00 0.5 https://www.iconplc.com/insights/blog/2018/04/17/leveraging-voice-assistant-technology-in-clinical-trials 2026-02-18T18:10:18+00:00 0.5 https://www.iconplc.com/insights/blog/2018/04/17/mhealth-better-treatments-and-clinical-outcomes 2026-02-18T18:04:42+00:00 0.5 https://www.iconplc.com/insights/blog/2018/04/17/regenerative-medicine-advanced-therapy-designation 2026-01-26T11:16:05+00:00 0.5 https://www.iconplc.com/insights/blog/2018/04/18/fda-rule-medical-devicel-symbols 2024-05-03T11:24:36+01:00 0.5 https://www.iconplc.com/insights/blog/2018/04/18/fewer-third-party-device-iso-report-auditors 2025-04-14T13:26:17+01:00 0.5 https://www.iconplc.com/insights/blog/2018/04/18/five-cybersecurity-threats 2026-02-04T09:10:08+00:00 0.5 https://www.iconplc.com/insights/blog/2018/04/18/immuno-oncology-choosing-the-right-biomarker 2026-03-19T14:38:30+00:00 0.5 https://www.iconplc.com/insights/blog/2018/04/19/activity-in-copd-populations 2026-01-22T08:42:11+00:00 0.5 https://www.iconplc.com/insights/blog/2018/04/19/limitations-multiple-myeloma-trials 2026-02-03T09:09:12+00:00 0.5 https://www.iconplc.com/insights/blog/2018/04/19/motion-based-gaming-to-measure-health 2026-02-18T17:58:52+00:00 0.5 https://www.iconplc.com/insights/blog/2018/04/19/real-time-monitoring-of-the-digital-patient 2026-02-18T17:51:15+00:00 0.5 https://www.iconplc.com/insights/blog/2018/04/20/fda-guidance-on-postmarket-cybersecurity 2026-02-04T11:37:59+00:00 0.5 https://www.iconplc.com/insights/blog/2018/04/20/revised-common-rule-for-the-protection-of-human-subjects 2026-02-04T11:41:25+00:00 0.5 https://www.iconplc.com/insights/blog/2018/04/20/scientific-publications-technology-solutions 2026-02-05T12:25:26+00:00 0.5 https://www.iconplc.com/insights/blog/2018/04/23/launching-a-patient-registry 2026-02-24T11:37:23+00:00 0.5 https://www.iconplc.com/insights/blog/2018/04/23/leveraging-smartphone-potential-for-clinical-trials 2026-02-18T17:46:04+00:00 0.5 https://www.iconplc.com/insights/blog/2018/04/23/physical-activity-and-exercise-for-alzheimers-disease 2026-02-24T11:40:14+00:00 0.5 https://www.iconplc.com/insights/blog/2018/04/24/measuring-free-living-activity-in-clinical-trials 2026-02-06T14:05:30+00:00 0.5 https://www.iconplc.com/insights/blog/2018/04/24/the-fdas-ldt-report 2026-01-26T14:40:49+00:00 0.5 https://www.iconplc.com/insights/blog/2018/04/30/fda-issues-draft-guidance 2026-02-04T11:52:40+00:00 0.5 https://www.iconplc.com/insights/blog/2018/05/18/data-driven-site-selection-aids-accelerated-study-start-up 2026-01-26T12:30:02+00:00 0.5 https://www.iconplc.com/insights/blog/2018/05/18/the-power-of-ai-to-transform-clinical-trials 2026-02-04T11:59:36+00:00 0.5 https://www.iconplc.com/insights/blog/2018/05/21/fda-draft-guidance-on-medical-devices 2024-05-03T11:36:27+01:00 0.5 https://www.iconplc.com/insights/blog/2018/05/25/controlling-logistics-costs 2026-02-05T14:37:49+00:00 0.5 https://www.iconplc.com/insights/blog/2018/05/28/measuring-the-impact-of-physical-activity-and-exercise-on-alzheimers-disease 2024-04-19T13:38:06+01:00 0.5 https://www.iconplc.com/insights/blog/2018/05/28/multimedia-approach-to-econsent 2026-02-24T12:16:42+00:00 0.5 https://www.iconplc.com/insights/blog/2018/06/07/making-the-move-to-virtual-clinical-trials 2026-03-04T11:34:37+00:00 0.5 https://www.iconplc.com/insights/blog/2018/06/13/biostatistics-using-rmst- 2026-01-26T14:52:28+00:00 0.5 https://www.iconplc.com/insights/blog/2018/06/25/fda-acceptance-of-clinica 2026-02-04T12:04:15+00:00 0.5 https://www.iconplc.com/insights/blog/2018/07/04/what-motivates-patients-to-participate-in-multiple-clinical-trials 2026-02-05T14:35:06+00:00 0.5 https://www.iconplc.com/insights/blog/2018/08/15/beyond-oncology-companion-diagnostics-and-biomarkers-for-other-therapeutic-areas 2026-02-05T12:23:15+00:00 0.5 https://www.iconplc.com/insights/blog/2018/08/31/introduction-to-applications-of-adaptive-design 2024-05-02T13:37:34+01:00 0.5 https://www.iconplc.com/insights/blog/2018/09/10/the-final-countdown-to-th 2026-02-03T09:14:34+00:00 0.5 https://www.iconplc.com/insights/blog/2018/09/18/smart-bioanalytical-strategies-immuno-oncology-trials 2026-02-26T15:32:32+00:00 0.5 https://www.iconplc.com/insights/blog/2018/09/20/analysis-results-metadata 2026-01-27T10:59:40+00:00 0.5 https://www.iconplc.com/insights/blog/2018/10/09/ema-iso-idmp-the-path-forward 2025-04-14T13:31:07+01:00 0.5 https://www.iconplc.com/insights/blog/2018/11/05/managing-clinical-trial-training 2026-01-27T11:30:49+00:00 0.5 https://www.iconplc.com/insights/blog/2018/11/30/biosimilar-trial-design 2026-03-23T07:12:30+00:00 0.5 https://www.iconplc.com/insights/blog/2018/12/07/an-introduction-to-applications-of-adaptive-design 2026-03-20T14:35:00+00:00 0.5 https://www.iconplc.com/insights/blog/2019/01/07/the-demand-for-reliable-predictions-to-limit-potential-carcinogenic-risk-in-drug-development 2026-02-05T13:13:36+00:00 0.5 https://www.iconplc.com/insights/blog/2019/01/24/convergent-development 2026-02-16T07:21:34+00:00 0.5 https://www.iconplc.com/insights/blog/2019/03/14/digital-health 2026-02-16T07:22:31+00:00 0.5 https://www.iconplc.com/insights/blog/2019/05/15/improving-results-in-patient-recruitment-and-engagement 2026-02-06T14:17:52+00:00 0.5 https://www.iconplc.com/insights/blog/2019/05/18/biosimilar-development-in-ophthalmology 2026-02-18T16:39:41+00:00 0.5 https://www.iconplc.com/insights/blog/2019/05/23/digitization-of-clinical-drug-development 2026-02-04T11:53:43+00:00 0.5 https://www.iconplc.com/insights/blog/2019/05/30/towards-a-data-driven-feasibility-assessment 2026-02-06T14:14:21+00:00 0.5 https://www.iconplc.com/insights/blog/2019/06/10/act-trials-demand-that-sites-act-differently 2026-02-04T11:55:35+00:00 0.5 https://www.iconplc.com/insights/blog/2019/06/17/new-mdr-rules 2026-02-04T11:57:27+00:00 0.5 https://www.iconplc.com/insights/blog/2019/07/22/patient-centricity-oncology-trials 2026-02-06T14:13:46+00:00 0.5 https://www.iconplc.com/insights/blog/2019/07/29/insights-from-inside-the-mmandm-awards-jury-room 2026-02-06T14:12:39+00:00 0.5 https://www.iconplc.com/insights/blog/2019/08/12/alexa-what-is-the-deal-with-voice-assistants 2026-02-04T11:58:55+00:00 0.5 https://www.iconplc.com/insights/blog/2019/09/10/the-importance-of-the-patient-voice-in-the-rare-disease-market 2026-02-24T10:43:22+00:00 0.5 https://www.iconplc.com/insights/blog/2019/09/16/key-considerations-for-parkinsons-disease-trials 2026-02-06T14:10:46+00:00 0.5 https://www.iconplc.com/insights/blog/2019/09/19/can-ai-improve-rd-productivity 2026-02-16T07:23:18+00:00 0.5 https://www.iconplc.com/insights/blog/2019/09/26/pharma-roi-restoration 2026-02-04T12:02:35+00:00 0.5 https://www.iconplc.com/insights/blog/2019/09/26/top-five-digital-technologies-transform-pharma-rd 2026-02-04T12:04:33+00:00 0.5 https://www.iconplc.com/insights/blog/2019/09/30/the-rare-disease-revolution 2026-02-04T12:05:38+00:00 0.5 https://www.iconplc.com/insights/blog/2019/10/24/4-challenges-to-successful-rare-disease-drug-development 2026-02-06T14:08:30+00:00 0.5 https://www.iconplc.com/insights/blog/2019/11/27/innovation-in-oncology-drug-development 2026-01-28T12:46:44+00:00 0.5 https://www.iconplc.com/insights/blog/2020/01/14/changes-in-clinical-safety-reporting-to-us-fda 2026-02-04T12:06:26+00:00 0.5 https://www.iconplc.com/insights/blog/2020/01/23/the-use-of-immunotherapy-in-cancer-treatment 2026-01-28T13:57:06+00:00 0.5 https://www.iconplc.com/insights/blog/2020/03/12/preparing-for-disease-x-a-look-at-the-potential-impact-of-coronavirus 2026-02-09T11:02:01+00:00 0.5 https://www.iconplc.com/insights/blog/2020/03/19/covid-19-influenza-and-cardiovascular-disease 2026-02-04T08:27:44+00:00 0.5 https://www.iconplc.com/insights/blog/2020/03/25/how-the-iomt-is-streamlining-clinical-operations 2026-03-04T11:28:40+00:00 0.5 https://www.iconplc.com/insights/blog/2020/03/25/managing-trial-participants-with-cardiovascular-and-metabolic-disease-during-covid19 2026-02-04T12:36:51+00:00 0.5 https://www.iconplc.com/insights/blog/2020/04/06/covid-19-vaccine-trials 2026-02-04T13:07:00+00:00 0.5 https://www.iconplc.com/insights/blog/2020/04/07/five-common-literature-reviews-for-rwe-generation 2026-02-04T13:11:58+00:00 0.5 https://www.iconplc.com/insights/blog/2020/04/08/the-importance-of-formulation-studies-in-drug-development 2026-01-29T10:41:28+00:00 0.5 https://www.iconplc.com/insights/blog/2020/04/17/diagnostics-on-the-frontlines-of-covid-19 2026-02-04T13:13:29+00:00 0.5 https://www.iconplc.com/insights/blog/2020/04/28/wearables-and-digital-end 2026-02-04T13:15:36+00:00 0.5 https://www.iconplc.com/insights/blog/2020/04/29/the-impact-of-covid-19-on-pharmacovigilance 2026-02-04T13:16:55+00:00 0.5 https://www.iconplc.com/insights/blog/2020/05/27/the-differences-between-the-us-and-eu-biosimilar-markets 2026-01-29T12:22:51+00:00 0.5 https://www.iconplc.com/insights/blog/2020/05/30/improving-access-and-reimbursement-for-specialty-therapies 2026-01-29T14:17:50+00:00 0.5 https://www.iconplc.com/insights/blog/2020/06/18/juvenile-arthritis-awareness-month 2026-01-29T14:24:06+00:00 0.5 https://www.iconplc.com/insights/blog/2020/06/22/enabling-clinical-development-of-cell-and-gene-therapies-on-a-global-basis 2026-02-06T13:57:42+00:00 0.5 https://www.iconplc.com/insights/blog/2020/07/14/encouraging-patient-participation-in-real-world-studies 2026-02-04T13:18:05+00:00 0.5 https://www.iconplc.com/insights/blog/2020/07/29/effective-patient-recruitment-for-rare-disease-research 2026-02-06T13:57:05+00:00 0.5 https://www.iconplc.com/insights/blog/2020/08/05/best-practices-for-design 2026-03-10T11:19:23+00:00 0.5 https://www.iconplc.com/insights/blog/2020/08/05/post-pandemic-clinical-tr 2026-02-04T13:25:44+00:00 0.5 https://www.iconplc.com/insights/blog/2020/08/05/remote-management-the-new 2026-02-04T13:27:10+00:00 0.5 https://www.iconplc.com/insights/blog/2020/08/20/iso-14155-medical-device-regulations 2026-02-04T13:28:06+00:00 0.5 https://www.iconplc.com/insights/blog/2020/09/11/Reducing-disruptions-of-cardiovascular-trials 2026-02-06T13:50:27+00:00 0.5 https://www.iconplc.com/insights/blog/2020/09/24/mapping-digital-health-transformation 2026-03-10T11:17:02+00:00 0.5 https://www.iconplc.com/insights/blog/2020/09/24/wearables-across-phases 2026-02-04T13:35:32+00:00 0.5 https://www.iconplc.com/insights/blog/2020/10/07/safety-reporting-in-latam 2026-02-04T13:38:00+00:00 0.5 https://www.iconplc.com/insights/blog/2020/11/11/data-capture-the-benefits-and-evolution-of-ecoa 2026-03-04T11:27:15+00:00 0.5 https://www.iconplc.com/insights/blog/2020/11/11/dirty-data-how-to-manage-data-from-wearables-in-clinical-trials 2026-03-04T11:31:01+00:00 0.5 https://www.iconplc.com/insights/blog/2020/11/16/agile-clinical-monitoring-the-flexibility-to-adapt-to-study-dynamics 2026-02-06T13:49:20+00:00 0.5 https://www.iconplc.com/insights/blog/2020/11/19/bringing-an-invisible-battle-to-the-forefront 2026-02-06T13:47:40+00:00 0.5 https://www.iconplc.com/insights/blog/2020/11/19/c-diff-and-covid-19 2026-01-30T11:58:03+00:00 0.5 https://www.iconplc.com/insights/blog/2020/12/04/harnessing-digital-health-to-advance-tbi-clinical-trials 2026-03-04T11:32:49+00:00 0.5 https://www.iconplc.com/insights/blog/2020/12/30/cancer-research-post-covid-19 2026-02-06T09:59:58+00:00 0.5 https://www.iconplc.com/insights/blog/2021/01/06/exploring-the-benefits-of-biotech-partnerships 2026-02-04T13:43:32+00:00 0.5 https://www.iconplc.com/insights/blog/2021/01/08/managing-covid-disruptions-within-ivdr-timelines 2026-02-04T13:51:00+00:00 0.5 https://www.iconplc.com/insights/blog/2021/01/08/risk-vigilance-and-remediation-under-ivdr 2026-02-06T07:59:56+00:00 0.5 https://www.iconplc.com/insights/blog/2021/01/27/hiv-mrna 2024-06-19T08:46:23+01:00 0.5 https://www.iconplc.com/insights/blog/2021/02/25/sharing-my-rare-disease-story-amanda-huber 2026-02-06T07:58:31+00:00 0.5 https://www.iconplc.com/insights/blog/2021/02/25/sharing-my-rare-disease-story-hayley-christensen 2026-02-06T07:57:49+00:00 0.5 https://www.iconplc.com/insights/blog/2021/02/25/sharing-my-rare-disease-story-julia-tonge 2026-02-06T08:00:52+00:00 0.5 https://www.iconplc.com/insights/blog/2021/02/25/sharing-my-rare-disease-story-tamie-joeckel 2026-02-06T07:56:48+00:00 0.5 https://www.iconplc.com/insights/blog/2021/03/16/navigating-complexity-in-oncology-cell-and-gene-therapy-clinical-trials 2026-02-06T07:55:42+00:00 0.5 https://www.iconplc.com/insights/blog/2021/03/20/multidiagnostic-approaches-for-patient-selection-biomarkers-in-immuno-oncology 2026-02-06T07:54:00+00:00 0.5 https://www.iconplc.com/insights/blog/2021/03/20/navigating-complexity-of-cell-therapy-during-the-covid19-pandemic 2026-02-05T14:40:04+00:00 0.5 https://www.iconplc.com/insights/blog/2021/03/22/hiv-africa 2026-02-04T13:53:39+00:00 0.5 https://www.iconplc.com/insights/blog/2021/03/24/cell-and-gene-therapy-trials 2026-02-05T14:47:55+00:00 0.5 https://www.iconplc.com/insights/blog/2021/04/01/innovation-in-oncology-dr 2026-02-05T14:46:56+00:00 0.5 https://www.iconplc.com/insights/blog/2021/04/07/the-role-of-technology-in-parkinsons-disease-treatment 2026-03-04T11:37:28+00:00 0.5 https://www.iconplc.com/insights/blog/2021/04/08/trends-in-health-economic 2026-02-24T10:40:59+00:00 0.5 https://www.iconplc.com/insights/blog/2021/04/21/role-of-data-in-revolutionising-the-CRO-industry 2026-02-18T12:45:37+00:00 0.5 https://www.iconplc.com/insights/blog/2021/05/10/managed-access-programs-as-an-alternative-to-ltfu-studies 2024-04-17T18:29:47+01:00 0.5 https://www.iconplc.com/insights/blog/2021/06/11/how-to-improve-participation-of-asymptomatic-patients-in-neurodegenerative-disease-registries 2024-07-10T14:24:46+01:00 0.5 https://www.iconplc.com/insights/blog/2021/06/22/leveraging-in-home-services-for-parkinsons-disease 2024-07-23T14:05:47+01:00 0.5 https://www.iconplc.com/insights/blog/2021/06/28/anatomic-pathology-in-the-digital-age 2026-02-26T13:37:35+00:00 0.5 https://www.iconplc.com/insights/blog/2021/06/29/battling-hiv-on-many-fronts 2026-02-05T14:42:22+00:00 0.5 https://www.iconplc.com/insights/blog/2021/08/06/assessing-the-need-for-primary-supporting-clinical-evidence-or-post-market-clinical-follow-up-under-mdr 2026-02-05T08:20:50+00:00 0.5 https://www.iconplc.com/insights/blog/2021/08/19/the-promise-of-glycomics-in-medicine 2024-04-17T18:40:51+01:00 0.5 https://www.iconplc.com/insights/blog/2021/09/20/rare-disease-patients-and-advocates-drive-change-in-public-policy 2026-02-05T13:25:45+00:00 0.5 https://www.iconplc.com/insights/blog/2021/10/01/icon-joins-unicef-corporate-vaccine-alliance 2024-07-23T14:15:00+01:00 0.5 https://www.iconplc.com/insights/blog/2021/10/19/the-impact-of-the-covid-19-pandemic-on-mental-health 2026-02-05T08:24:10+00:00 0.5 https://www.iconplc.com/insights/blog/2021/10/26/data-disruption-navigating-cardiovascular-clinical-trial-adjudication-during-a-respiratory-pandemic 2026-02-05T08:27:32+00:00 0.5 https://www.iconplc.com/insights/blog/2021/10/31/you-attract-what-you-are-how-we-can-continue-building-a-diverse-equal-and-inclusive-industry 2024-11-27T09:02:49+00:00 0.5 https://www.iconplc.com/insights/blog/2021/11/01/diverse-clinical-research-starts-with-the-healthcare-workforce 2026-02-05T08:28:48+00:00 0.5 https://www.iconplc.com/insights/blog/2021/11/10/ec-proposes-extended-transition-period-for-ivdr-compliance 2026-02-04T10:31:37+00:00 0.5 https://www.iconplc.com/insights/blog/2022/01/07/combatting-amr-with-new-tools-to-diagnose-and-treat-infectious-disease 2026-02-05T13:23:49+00:00 0.5 https://www.iconplc.com/insights/blog/2022/05/11/how-joint-venture-models-can-boost-japans-pharma-industry 2024-11-27T12:19:16+00:00 0.5 https://www.iconplc.com/insights/blog/2022/05/18/ICON-is-celebrating-its-first-inclusion-day 2026-02-05T13:19:09+00:00 0.5 https://www.iconplc.com/insights/blog/2022/05/26/cell-and-gene-therapy-specific-market-authorisation-guidances 2026-02-04T11:39:35+00:00 0.5 https://www.iconplc.com/insights/blog/2022/06/08/interviews-with-patients-in-clinical-trials 2026-03-19T14:52:15+00:00 0.5 https://www.iconplc.com/insights/blog/2022/06/14/using-bayesian-based-model-assisted-designs-in-early-phase-oncology-trials 2026-02-05T13:12:52+00:00 0.5 https://www.iconplc.com/insights/blog/2022/07/20/clinical-trials-through-a-childs-eyes 2026-02-06T14:58:38+00:00 0.5 https://www.iconplc.com/insights/blog/2022/09/12/reflections-on-ICONs-2021-esg-report 2026-02-04T12:24:43+00:00 0.5 https://www.iconplc.com/insights/blog/2022/09/19/advanced-therapies-rare-disease-regulatory-roadmap 2026-02-04T12:29:20+00:00 0.5 https://www.iconplc.com/insights/blog/2022/09/19/clinical-development-challenges-faced-advanced-therapies-rare-disease 2026-02-05T08:33:46+00:00 0.5 https://www.iconplc.com/insights/blog/2022/09/28/hassle-free-trial-translation-services 2026-02-05T08:35:52+00:00 0.5 https://www.iconplc.com/insights/blog/2022/10/06/cgt-manufacturing-handling-and-delivery 2024-04-18T12:13:48+01:00 0.5 https://www.iconplc.com/insights/blog/2022/10/06/navigating-complex-cgt-clinical-trial-design 2026-02-04T13:43:14+00:00 0.5 https://www.iconplc.com/insights/blog/2022/10/06/scaling-up-to-cgt-commercialisation 2024-06-18T15:19:59+01:00 0.5 https://www.iconplc.com/insights/blog/2022/10/18/strategic-partnerships-within-language-and-translation-services 2026-02-18T12:07:59+00:00 0.5 https://www.iconplc.com/insights/blog/2022/11/10/keep-ecoa-off-the-critical-path-of-clinical-trial-startup 2026-02-04T14:23:18+00:00 0.5 https://www.iconplc.com/insights/blog/2022/11/10/key-success-factors-for-linguistic-validation-and-coa-translations 2026-02-09T11:41:41+00:00 0.5 https://www.iconplc.com/insights/blog/2022/11/14/collaborating-with-patient-advocacy-organisations-for-rare-disease-registries 2026-02-04T14:38:40+00:00 0.5 https://www.iconplc.com/insights/blog/2022/11/17/empowering-children-with-education-through-clinical-trials 2026-02-04T14:41:45+00:00 0.5 https://www.iconplc.com/insights/blog/2022/11/18/cmc-in-drug-development-and-life-cycle-management 2026-02-09T12:21:26+00:00 0.5 https://www.iconplc.com/insights/blog/2022/11/18/understanding-the-impact-of-the-clinical-trial-liaison 2026-02-04T15:03:06+00:00 0.5 https://www.iconplc.com/insights/blog/2022/11/23/us-marketing-approval-of-drugs-and-devices-on-foreign-clinical-data 2026-02-05T08:37:06+00:00 0.5 https://www.iconplc.com/insights/blog/2022/11/29/medical-device-classification-and-applicable-FDA-regulations 2026-02-05T10:24:20+00:00 0.5 https://www.iconplc.com/insights/blog/2022/11/30/mdr-certification-bottleneck 2026-02-05T10:43:27+00:00 0.5 https://www.iconplc.com/insights/blog/2022/12/01/implementing-surveillance-measures-prioritise-patient-safety 2026-02-05T10:48:43+00:00 0.5 https://www.iconplc.com/insights/blog/2022/12/06/pharmacovigilance-outsourcing-tips-selecting-service-provider 2026-02-05T10:53:38+00:00 0.5 https://www.iconplc.com/insights/blog/2022/12/08/filling-the-gaps-for-rare-and-orphan-diseases 2026-02-05T10:56:17+00:00 0.5 https://www.iconplc.com/insights/blog/2022/12/15/crafting-a-competitive-biotech-funding-pitch 2026-02-05T11:01:10+00:00 0.5 https://www.iconplc.com/insights/blog/2023/01/13/impact-real-world-evidence-drug-marketing-approval-and-reimbursement 2026-02-05T11:24:39+00:00 0.5 https://www.iconplc.com/insights/blog/2022/12/20/optimising-biotech-trial-designs-stretch-your-cash-runway 2026-02-05T11:26:30+00:00 0.5 https://www.iconplc.com/insights/blog/2023/01/06/redefining-sourcing-model-terminology 2026-02-05T11:32:03+00:00 0.5 https://www.iconplc.com/insights/blog/2023/01/18/importance-developing-rtpp-build-biotech-asset-value 2026-02-05T11:34:56+00:00 0.5 https://www.iconplc.com/insights/blog/2023/02/03/my-patient-story-chelsea-mason 2026-02-05T11:40:55+00:00 0.5 https://www.iconplc.com/insights/blog/2023/02/03/my-patient-story-claudia-egremont-lee 2026-02-05T11:44:01+00:00 0.5 https://www.iconplc.com/insights/blog/2023/02/03/my-patient-story-margaritte-de-falco 2026-02-05T11:47:36+00:00 0.5 https://www.iconplc.com/insights/blog/2023/02/22/rare-disease-day-diversity-and-inclusion 2026-02-05T11:50:59+00:00 0.5 https://www.iconplc.com/insights/blog/2023/04/21/pre-emptive-vaccine-research-improve-eid-response 2026-02-05T11:54:23+00:00 0.5 https://www.iconplc.com/insights/blog/2023/03/24/mary-oreilly-reflects-on-international-womens-day 2026-02-05T12:02:17+00:00 0.5 https://www.iconplc.com/insights/blog/2023/03/16/positive-step-diversity-and-inclusion-clinical-trials-reflections-fdora 2026-02-05T12:20:00+00:00 0.5 https://www.iconplc.com/insights/blog/2023/04/13/from-clinician-visits-to-data-analysis 2026-02-05T12:25:04+00:00 0.5 https://www.iconplc.com/insights/blog/2023/04/24/improving-experience-healthy-volunteers-during-early-phase-clinical-trials 2026-02-05T12:32:27+00:00 0.5 https://www.iconplc.com/insights/blog/2023/04/18/use-ddpcr-and-qpcr-assays-pk-and-safety-monitoring-cell-gene-therapy 2026-02-05T12:34:28+00:00 0.5 https://www.iconplc.com/insights/blog/2023/05/15/impact-new-eu-clinical-trial-regulation-language-translation 2026-02-05T12:37:35+00:00 0.5 https://www.iconplc.com/insights/blog/2023/05/05/trends-in-the-biotech-funding-environment 2026-02-05T12:40:07+00:00 0.5 https://www.iconplc.com/insights/blog/2023/05/15/biotechs-evolving-relationship-cros 2026-02-05T12:44:33+00:00 0.5 https://www.iconplc.com/insights/blog/2023/06/13/rare-diseases-and-orphan-drugs-regulatory-framework-canada 2025-02-26T12:14:38+00:00 0.5 https://www.iconplc.com/insights/blog/2023/06/19/eu-ctr-practical-experiences-and-lessons-learned 2024-04-18T13:10:46+01:00 0.5 https://www.iconplc.com/insights/blog/2023/06/26/disease-surveillance 2026-02-05T13:58:51+00:00 0.5 https://www.iconplc.com/insights/blog/2023/07/19/disease-surveillance-and-innovative-vaccines 2024-06-03T13:53:05+01:00 0.5 https://www.iconplc.com/insights/blog/2023/07/24/best-practices-kpi-management-fsp-partnerships 2026-02-05T14:02:11+00:00 0.5 https://www.iconplc.com/insights/blog/2023/07/27/patient-centric-best-practices-improved-diversity 2026-02-05T14:06:27+00:00 0.5 https://www.iconplc.com/insights/blog/2023/08/16/new-ema-guideline-expectations 2026-02-05T14:10:32+00:00 0.5 https://www.iconplc.com/insights/blog/2023/08/22/highlights-revised-medicare-drug-price-negotiation-program-guidance 2026-02-05T14:19:34+00:00 0.5 https://www.iconplc.com/insights/blog/2023/09/28/realising-benefits-bringing-decentralised-cardiovascular-trials-patients 2026-02-05T14:24:39+00:00 0.5 https://www.iconplc.com/insights/blog/2023/10/06/keeping-date-latest-regulatory-developments-decentralised-clinical-trials 2026-02-05T14:28:39+00:00 0.5 https://www.iconplc.com/insights/blog/2023/10/06/car-t-cell-therapy 2026-02-05T14:33:16+00:00 0.5 https://www.iconplc.com/insights/blog/2023/10/11/digital-therapeutics-considerations-cns 2026-02-05T14:38:04+00:00 0.5 https://www.iconplc.com/insights/blog/2023/10/26/navigating-ctis-setting-clinical-trials-under-eu-ctr 2026-02-05T14:43:23+00:00 0.5 https://www.iconplc.com/insights/blog/2023/11/08/impact-pediatric-medical-trauma-clinical-trials 2026-02-05T14:47:30+00:00 0.5 https://www.iconplc.com/insights/blog/2023/11/16/continuing-fight-against-amr-new-tools-diagnosis-and-treatment 2025-02-26T12:16:23+00:00 0.5 https://www.iconplc.com/insights/blog/2023/12/13/trialing-abroad-how-sponsors-ethics-committees-and-regulators-improve 2026-02-05T15:01:05+00:00 0.5 https://www.iconplc.com/insights/blog/2023/12/14/how-data-intelligence-tools-are-enhancing-signal-detection-methods 2024-07-23T14:23:33+01:00 0.5 https://www.iconplc.com/insights/blog/2024/01/12/how-pharma-can-use-sdoh-address-health-equity 2026-02-16T07:24:05+00:00 0.5 https://www.iconplc.com/insights/blog/2024/01/26/ensuring-safety-and-compliance-essentials-outsourcing-pharmacovigilance 2026-02-09T11:01:21+00:00 0.5 https://www.iconplc.com/insights/blog/2024/02/13/insights-2024-iscr-annual-conference-indias-evolving-clinical-research 2026-02-09T11:06:17+00:00 0.5 https://www.iconplc.com/insights/blog/2024/02/21/strategies-de-risking-rare-disease-programmes-during-research-and 2024-06-03T13:14:08+01:00 0.5 https://www.iconplc.com/insights/blog/2024/02/21/rare-disease-trials-require-effective-participation-support-strategies 2024-07-08T14:45:05+01:00 0.5 https://www.iconplc.com/insights/blog/2024/02/28/beyond-awareness-driving-progress-rare-disease-journey 2024-04-16T16:29:27+01:00 0.5 https://www.iconplc.com/insights/blog/2024/03/15/insights-2024-phuse-us-connect 2026-02-09T11:17:22+00:00 0.5 https://www.iconplc.com/insights/blog/2024/03/25/site-training-clinical-trial-success 2026-02-09T11:21:18+00:00 0.5 https://www.iconplc.com/insights/blog/2024/03/27/diabesity-overlapping-pathophysiology-informs-multi-indication-treatment 2024-06-03T13:10:21+01:00 0.5 https://www.iconplc.com/insights/blog/2024/04/01/sdoh-data-efficient-patient-centred-clinical-trials 2024-07-23T14:26:25+01:00 0.5 https://www.iconplc.com/insights/blog/2024/04/25/complexities-running-clinical-trial-retinal-disorders-and-ways-overcome 2026-03-19T11:25:30+00:00 0.5 https://www.iconplc.com/insights/blog/2024/04/26/how-ai-could-transform-literature-surveillance-pharmacovigilance 2026-02-10T11:01:32+00:00 0.5 https://www.iconplc.com/insights/blog/2024/05/01/cross-border-initiative-empower-rare-disease-researchers 2026-02-09T11:26:08+00:00 0.5 https://www.iconplc.com/insights/blog/2024/05/09/navigating-complexities-healthcare-data-types 2024-07-23T14:25:06+01:00 0.5 https://www.iconplc.com/insights/blog/2024/05/10/sdoh-data-analysis-proactive-outcome-improvement-multilayered-approach 2025-04-15T14:55:25+01:00 0.5 https://www.iconplc.com/insights/blog/2024/05/10/integrating-performance-studies-vitro-diagnostics-clinical-trials-complex 2024-05-16T07:45:19+01:00 0.5 https://www.iconplc.com/insights/blog/2024/05/21/unlocking-quality-machine-translation-impact-iso-18587-certification 2024-11-27T14:17:41+00:00 0.5 https://www.iconplc.com/insights/blog/2024/06/04/navigating-regulatory-landscapes-guide-global-submission-standards 2026-02-10T11:06:22+00:00 0.5 https://www.iconplc.com/insights/blog/2024/06/04/icon-scdm-2024-connecting-dots-clinical-data-management 2026-02-10T11:04:12+00:00 0.5 https://www.iconplc.com/insights/blog/2024/06/06/next-frontier-digital-health-and-patient-safety 2026-02-09T11:29:41+00:00 0.5 https://www.iconplc.com/insights/blog/2024/06/14/rise-and-role-ai-medical-imaging 2026-02-16T07:25:20+00:00 0.5 https://www.iconplc.com/insights/blog/2024/06/21/veeva-rd-and-quality-summit 2026-02-10T11:11:25+00:00 0.5 https://www.iconplc.com/insights/blog/2024/06/26/leveraging-healthcare-intelligence-increase-diversity-oncology-clinical 2024-08-15T09:51:25+01:00 0.5 https://www.iconplc.com/insights/blog/2024/06/26/navigating-oncology-development-decisions-long-term-success 2024-07-25T08:54:17+01:00 0.5 https://www.iconplc.com/insights/blog/2024/06/26/innovations-contributing-reemergence-antibody-drug-conjugates 2024-06-27T13:38:15+01:00 0.5 https://www.iconplc.com/insights/blog/2024/06/26/navigating-shifting-paradigms-dose-optimisation-and-dose-selection 2024-08-15T10:04:38+01:00 0.5 https://www.iconplc.com/insights/blog/2024/07/02/how-human-enabled-ai-creating-new-map-navigating-site-selection 2026-02-10T11:16:04+00:00 0.5 https://www.iconplc.com/insights/blog/2024/07/02/innovative-approaches-ensuring-participant-safety-early-phase-clinical 2026-02-09T11:35:17+00:00 0.5 https://www.iconplc.com/insights/blog/2024/07/04/essential-components-successful-global-labelling-process 2025-03-04T10:55:43+00:00 0.5 https://www.iconplc.com/insights/blog/2024/07/04/pushing-boundaries-idiopathic-pulmonary-fibrosis-clinical-research 2026-01-08T17:12:32+00:00 0.5 https://www.iconplc.com/insights/blog/2024/07/04/race-develop-combination-vaccines-and-importance-indirect-effects 2024-08-14T00:00:00+01:00 0.5 https://www.iconplc.com/insights/blog/2024/07/10/defining-differences-when-regulating-medical-devices-medicinal-and 2026-02-09T11:39:44+00:00 0.5 https://www.iconplc.com/insights/blog/2024/07/15/insights-psi-2024-advancements-digital-health-technology 2024-07-15T09:04:51+01:00 0.5 https://www.iconplc.com/insights/blog/2024/07/15/transforming-cml-patient-monitoring-icons-innovative-rna-based-ngs-assay 2026-02-09T11:44:09+00:00 0.5 https://www.iconplc.com/insights/blog/2024/07/19/streamlining-clinical-trial-submissions-under-eu-ctr 2026-02-09T11:50:45+00:00 0.5 https://www.iconplc.com/insights/blog/2024/07/24/impact-ai-evolution-machine-translation 2024-11-27T14:15:49+00:00 0.5 https://www.iconplc.com/insights/blog/2024/08/02/digital-endpoints-widely-adopted-pharmaceutical-and-biotech-sponsored 2025-04-15T15:05:24+01:00 0.5 https://www.iconplc.com/insights/blog/2024/08/02/rise-precision-outcome-measures 2024-11-27T09:10:00+00:00 0.5 https://www.iconplc.com/insights/blog/2024/08/02/outcome-measures-driving-precision-health-strategies-forward 2024-08-21T08:25:08+01:00 0.5 https://www.iconplc.com/insights/blog/2024/08/02/enabling-new-way-select-fit-purpose-coas-simplify-clinical-protocols 2024-11-27T09:11:00+00:00 0.5 https://www.iconplc.com/insights/blog/2024/08/02/utilising-connected-sensors-power-diverse-and-equitable-clinical-trials 2025-03-10T15:03:53+00:00 0.5 https://www.iconplc.com/insights/blog/2024/08/02/tested-tried-and-true-why-digital-biomarkers-are-ai-ml-strategy-pharma 2026-02-05T08:52:31+00:00 0.5 https://www.iconplc.com/insights/blog/2024/08/14/understanding-chinas-2024-nrdl-key-changes-and-their-impact 2026-03-25T10:34:46+00:00 0.5 https://www.iconplc.com/insights/blog/2024/08/19/enhancing-diversity-clinical-trials-ai-and-human-expertise 2025-03-10T15:02:48+00:00 0.5 https://www.iconplc.com/insights/blog/2024/08/26/accelerating-atmp-and-cgt-importance-regulatory-cmc-expertise-efficient 2025-09-03T16:55:08+01:00 0.5 https://www.iconplc.com/insights/blog/2024/09/02/outcome-measures-driving-forward-patient-centered-clinical-trials 2025-03-10T15:00:25+00:00 0.5 https://www.iconplc.com/insights/blog/2024/09/09/medicare-part-d-price-negotiations-update-widespread-impact-industry 2024-10-02T23:41:31+01:00 0.5 https://www.iconplc.com/insights/blog/2024/09/09/navigating-impacts-inflation-reduction-act-ira-strategic-considerations 2025-05-29T10:01:54+01:00 0.5 https://www.iconplc.com/insights/blog/2024/09/24/submission-strategies-combined-studies-eu 2026-02-09T11:53:12+00:00 0.5 https://www.iconplc.com/insights/blog/2024/09/26/digital-health-managing-cybersecurity-risks 2026-02-09T11:56:10+00:00 0.5 https://www.iconplc.com/insights/blog/2024/09/27/digital-health-why-evaluating-human-factors-essential 2026-02-09T12:00:01+00:00 0.5 https://www.iconplc.com/insights/blog/2024/10/01/unlocking-value-transparent-healthcare-data 2024-11-15T13:27:24+00:00 0.5 https://www.iconplc.com/insights/blog/2024/10/07/enhancing-diversity-clinical-trials 2026-02-05T08:55:24+00:00 0.5 https://www.iconplc.com/insights/blog/2024/10/08/why-using-coas-and-dhts-together-future-clinical-research 2024-10-11T12:54:37+01:00 0.5 https://www.iconplc.com/insights/blog/2024/10/21/benefits-going-big-why-small-biotechs-need-large-cro-partners 2026-02-10T11:39:11+00:00 0.5 https://www.iconplc.com/insights/blog/2024/10/25/maximising-clinical-trial-success-integrated-language-services 2024-11-27T14:18:06+00:00 0.5 https://www.iconplc.com/insights/blog/2024/10/25/importance-robust-clinical-outcome-assessment-strategy-your-clinical-trial 2024-11-27T14:19:53+00:00 0.5 https://www.iconplc.com/insights/blog/2024/11/14/dynamic-market-trends-transforming-future-obesity-drug-development 2024-11-14T13:42:07+00:00 0.5 https://www.iconplc.com/insights/blog/2024/11/15/importance-communication-patient-centred-clinical-trials 2026-02-10T11:47:45+00:00 0.5 https://www.iconplc.com/insights/blog/2024/11/15/how-ecoa-library-can-reduce-your-study-start-timelines 2026-02-10T11:44:49+00:00 0.5 https://www.iconplc.com/insights/blog/2024/11/27/designing-clinical-trials-complex-disease-pediatric-obesity 2024-11-29T13:22:28+00:00 0.5 https://www.iconplc.com/insights/blog/2024/11/27/obesity-related-liver-conditions-understanding-treatment-options 2024-12-02T14:24:38+00:00 0.5 https://www.iconplc.com/insights/blog/2024/12/03/leading-early-phase-challenges-biotechs 2026-02-09T12:18:10+00:00 0.5 https://www.iconplc.com/insights/blog/2024/12/03/investigating-multi-indication-drug-targets 2024-12-06T07:15:27+00:00 0.5 https://www.iconplc.com/insights/blog/2024/12/04/data-transparency-variances-patient-and-claims-counts-explained 2025-09-03T16:52:44+01:00 0.5 https://www.iconplc.com/insights/blog/2024/12/06/how-prepare-ema-policy-0070 2026-02-10T11:50:25+00:00 0.5 https://www.iconplc.com/insights/blog/2024/12/10/celebrating-world-childrens-day 2024-12-11T15:45:12+00:00 0.5 https://www.iconplc.com/insights/blog/2024/12/13/advancing-pharmacovigilance-changing-landscape-2024-world-drug-safety 2026-02-10T11:53:38+00:00 0.5 https://www.iconplc.com/insights/blog/2024/12/19/how-coas-and-dhts-offer-deep-insights-patient-experiences-and-treatment 2025-02-03T13:45:07+00:00 0.5 https://www.iconplc.com/insights/blog/2025/01/03/new-opportunities-immunogenicity 2026-02-09T12:28:17+00:00 0.5 https://www.iconplc.com/insights/blog/2025/01/23/clinical-trial-linguists-perspective-machine-translation 2025-02-05T08:08:35+00:00 0.5 https://www.iconplc.com/insights/blog/2025/02/11/future-medical-science-depends-transparency-why-plain-language-summaries 2026-02-05T08:56:37+00:00 0.5 https://www.iconplc.com/insights/blog/2025/02/11/why-translating-core-dossiers-marketing-applications-requires-more 2025-02-12T08:28:06+00:00 0.5 https://www.iconplc.com/insights/blog/2025/02/11/integrated-approach-deeper-insight-both-open-and-closed-claims-data 2025-02-12T00:00:00+00:00 0.5 https://www.iconplc.com/insights/blog/2025/02/13/ich-gcp-e6-r3-transformative-updates-make-good-clinical-practice-better 2026-02-10T11:56:41+00:00 0.5 https://www.iconplc.com/insights/blog/2025/02/13/subtler-scopes-where-ira-drug-negotiations-meet-part-d-redesigns 2025-02-20T13:12:51+00:00 0.5 https://www.iconplc.com/insights/blog/2025/02/27/reassessing-uks-regulatory-landscape-post-brexit 2026-02-09T12:33:51+00:00 0.5 https://www.iconplc.com/insights/blog/2025/02/27/navigating-pediatric-drug-development-pdp-canada-comprehensive-guide-part 2026-02-09T13:36:52+00:00 0.5 https://www.iconplc.com/insights/blog/2025/03/04/endometriosis-research-and-development-call-action 2025-03-06T10:29:38+00:00 0.5 https://www.iconplc.com/insights/blog/2025/03/10/navigating-pediatric-drug-development-pdp-canada-comprehensive-guide-part 2026-02-09T13:40:13+00:00 0.5 https://www.iconplc.com/insights/blog/2025/03/14/making-sense-regulatory-web-governing-biosimilars-development-across-apac 2026-02-10T12:01:56+00:00 0.5 https://www.iconplc.com/insights/blog/2025/03/14/insights-2025-iscr-conference 2026-02-10T11:59:17+00:00 0.5 https://www.iconplc.com/insights/blog/2025/03/21/validated-tokens-key-following-patient-journey 2025-03-24T14:36:52+00:00 0.5 https://www.iconplc.com/insights/blog/2025/03/25/clinical-trial-protocol-design-amid-evolving-global-ivd-regulations 2026-02-10T12:19:14+00:00 0.5 https://www.iconplc.com/insights/blog/2025/04/09/collaborating-protocol-perfection-holistic-approach-protocol-design 2025-04-10T09:59:41+01:00 0.5 https://www.iconplc.com/insights/blog/2025/04/09/controlling-complexity-regulator-ready-protocol 2025-04-10T09:58:08+01:00 0.5 https://www.iconplc.com/insights/blog/2025/04/10/partnered-perspective-2025-medidata-next-conference 2026-02-09T13:59:13+00:00 0.5 https://www.iconplc.com/insights/blog/2025/04/11/notes-tomorrows-biotech-insights-bio-europe-springs-expert-panel 2026-02-10T12:23:24+00:00 0.5 https://www.iconplc.com/insights/blog/2025/04/11/minimising-impurity-formation-oligonucleotide-synthesis 2026-02-09T14:02:59+00:00 0.5 https://www.iconplc.com/insights/blog/2025/04/11/implementing-digital-health-technologies-patient-centred-trials 2025-05-14T07:06:42+01:00 0.5 https://www.iconplc.com/insights/blog/2025/04/14/understanding-new-draft-fda-guidance-data-monitoring-committees 2026-02-10T12:25:56+00:00 0.5 https://www.iconplc.com/insights/blog/2025/04/14/when-and-why-sponsors-should-seek-mhra-advice 2026-02-09T14:06:09+00:00 0.5 https://www.iconplc.com/insights/blog/2025/04/16/cmc-imp-considerations-oligonucleotides 2026-02-09T14:09:54+00:00 0.5 https://www.iconplc.com/insights/blog/2025/04/17/tallying-troops-tracking-cost-implications-under-ira-part-d-reforms 2025-04-17T10:14:15+01:00 0.5 https://www.iconplc.com/insights/blog/2025/04/22/driving-maa-success-why-every-submission-team-needs-regulatory-project 2026-02-09T14:11:42+00:00 0.5 https://www.iconplc.com/insights/blog/2025/05/15/protocol-predictability-refocusing-through-lens-site-and-patient 2026-02-10T12:32:36+00:00 0.5 https://www.iconplc.com/insights/blog/2025/05/21/cultural-shift-iso-13485-2016-implementation-fda 2025-09-03T16:46:46+01:00 0.5 https://www.iconplc.com/insights/blog/2025/05/22/technology-and-tokenisation-reflections-2025-world-vaccine-congress 2026-02-10T12:46:08+00:00 0.5 https://www.iconplc.com/insights/blog/2025/05/23/oligonucleotide-progression-early-phase-studies 2026-02-09T14:13:36+00:00 0.5 https://www.iconplc.com/insights/blog/2025/05/29/post-marketing-pharmacovigilance-ensuring-product-safety-real-world 2026-02-10T12:47:39+00:00 0.5 https://www.iconplc.com/insights/blog/2025/06/09/how-global-capability-centres-deliver-value-healthcare-companies 2026-02-16T07:26:41+00:00 0.5 https://www.iconplc.com/insights/blog/2025/06/13/project-management-tips-successful-maa-nda-or-bla-submission-preparation 2026-02-10T12:51:07+00:00 0.5 https://www.iconplc.com/insights/blog/2025/06/19/writing-managing-leading-multifaceted-role-successful-medical-writer 2026-02-09T14:16:55+00:00 0.5 https://www.iconplc.com/insights/blog/2025/06/23/why-integration-essential-outsourced-regulatory-submissions 2025-06-24T07:23:29+01:00 0.5 https://www.iconplc.com/insights/blog/2025/06/23/solving-common-challenges-develop-oncology-combination-therapies 2025-06-25T16:30:01+01:00 0.5 https://www.iconplc.com/insights/blog/2025/06/24/fda-regulations-ai-medical-devices 2026-02-10T12:54:34+00:00 0.5 https://www.iconplc.com/insights/blog/2025/06/24/breakfast-biotech-expert-insights-early-stage-bioeuquity-europe-2025 2026-02-23T15:11:33+00:00 0.5 https://www.iconplc.com/insights/blog/2025/06/26/day-life-mark-sorrentino 2025-08-22T12:05:55+01:00 0.5 https://www.iconplc.com/insights/blog/2025/06/26/day-life-bojana-mirosavljevic 2025-08-22T12:06:29+01:00 0.5 https://www.iconplc.com/insights/blog/2025/06/26/day-life-heidi-hoppe 2025-08-22T12:05:21+01:00 0.5 https://www.iconplc.com/insights/blog/2025/06/30/biotech-success-start-end-mind-and-develop-tpp-early 2025-08-19T15:10:18+01:00 0.5 https://www.iconplc.com/insights/blog/2025/07/04/rethinking-womens-health 2025-07-23T16:28:17+01:00 0.5 https://www.iconplc.com/insights/blog/2025/07/10/redesigning-schizophrenia-trials-lessons-frontlines-cns-research 2026-02-25T12:01:49+00:00 0.5 https://www.iconplc.com/insights/blog/2025/07/10/why-assessing-pharmacokinetics-antibody-drug-conjugates-so-complex 2026-02-09T14:20:20+00:00 0.5 https://www.iconplc.com/insights/blog/2025/07/14/navigating-post-market-access-and-adoption-biosimilars-across-apac 2026-02-27T15:01:24+00:00 0.5 https://www.iconplc.com/insights/blog/2025/07/14/future-clinical-trials-why-patient-centric-outcome-measures-matter 2025-07-14T12:36:21+01:00 0.5 https://www.iconplc.com/insights/blog/2025/07/18/real-weight-real-world-data-key-factors-successful-real-world-data-rfprfi 2025-07-21T08:48:31+01:00 0.5 https://www.iconplc.com/insights/blog/2025/07/21/oncology-biosimilars-rise-key-clinical-development-insights 2026-03-02T11:56:29+00:00 0.5 https://www.iconplc.com/insights/blog/2025/07/21/revision-iso-10993-1-what-does-it-mean-medical-devices 2026-03-02T14:48:04+00:00 0.5 https://www.iconplc.com/insights/blog/2025/08/06/why-long-term-follow-should-start-early-vaccine-trials 2026-03-03T11:39:56+00:00 0.5 https://www.iconplc.com/insights/blog/2025/08/07/designing-delphi-panels-useful-non-standardised-tool-patient-centric 2025-08-08T14:26:52+01:00 0.5 https://www.iconplc.com/insights/blog/2025/08/11/how-gcp-updates-make-way-rbqm-revolution 2025-10-21T13:50:12+01:00 0.5 https://www.iconplc.com/insights/blog/2025/08/19/avoid-htar-bottlenecks-nice-and-mhra-offer-strategic-alternative 2025-08-19T11:00:46+01:00 0.5 https://www.iconplc.com/insights/blog/2025/08/19/rising-challenge-innovative-therapies 2026-02-09T14:35:27+00:00 0.5 https://www.iconplc.com/insights/blog/2025/08/20/importance-stability-programs-early-clinical-drug-product-development 2026-02-09T14:39:16+00:00 0.5 https://www.iconplc.com/insights/blog/2025/08/25/how-project-optimus-has-impacted-oncology-focussed-biotech-companies 2025-09-01T11:48:54+01:00 0.5 https://www.iconplc.com/insights/blog/2025/08/28/beyond-tradition-analysis-modern-vaccine-technologies 2026-03-03T14:56:00+00:00 0.5 https://www.iconplc.com/insights/blog/2025/09/17/getting-values-right-which-qt-correction-formula-most-accurate-healthy 2026-02-09T14:43:47+00:00 0.5 https://www.iconplc.com/insights/blog/2025/09/18/reimagining-clinical-programming-strategic-role-r-modern-trials 2026-02-09T14:45:59+00:00 0.5 https://www.iconplc.com/insights/blog/2025/09/18/modern-tools-cardiovascular-studies 2026-03-06T10:46:13+00:00 0.5 https://www.iconplc.com/insights/blog/2025/09/18/measuring-impact-ich-e9r1-uk-research-protocols 2026-03-05T15:45:10+00:00 0.5 https://www.iconplc.com/insights/blog/2025/09/24/challenges-free-payload-concentration-analysis-adc-studies 2026-02-09T14:48:39+00:00 0.5 https://www.iconplc.com/insights/blog/2025/09/30/driving-biosimilar-adoption-apac 2026-03-04T13:51:21+00:00 0.5 https://www.iconplc.com/insights/blog/2025/10/03/cmc-drug-development-and-life-cycle-management 2026-03-04T10:55:59+00:00 0.5 https://www.iconplc.com/insights/blog/2025/10/13/smarter-rbqm-intelligent-tools 2026-03-09T10:59:38+00:00 0.5 https://www.iconplc.com/insights/blog/2025/10/16/managing-risk-medical-devices 2026-02-09T14:56:50+00:00 0.5 https://www.iconplc.com/insights/blog/2025/10/16/customer-advocacy-strategic-imperative-regulatory-consultancy-excellence 2026-03-10T12:26:04+00:00 0.5 https://www.iconplc.com/insights/blog/2025/10/16/mitigating-data-disruptions-open-claims-datasets 2025-10-16T09:42:02+01:00 0.5 https://www.iconplc.com/insights/blog/2025/10/20/managing-risk-medical-devices-part-2 2026-03-11T13:27:42+00:00 0.5 https://www.iconplc.com/insights/blog/2025/10/23/enhancing-clinical-trials-obesity-integrating-coas-and-dhts 2026-03-10T15:56:36+00:00 0.5 https://www.iconplc.com/insights/blog/2025/10/27/strategies-successful-integrated-summary-iss-ise-submissions 2026-03-12T10:53:10+00:00 0.5 https://www.iconplc.com/insights/blog/2025/10/27/mash-liver-healths-silent-epidemic 2025-10-28T10:22:58+00:00 0.5 https://www.iconplc.com/insights/blog/2025/10/29/more-awareness-taking-action-address-ipv-sdoh-clinical-trials 2025-10-30T08:41:17+00:00 0.5 https://www.iconplc.com/insights/blog/2025/10/31/managing-risk-medical-devices-part-3 2026-02-09T15:00:04+00:00 0.5 https://www.iconplc.com/insights/blog/2025/11/06/biomarkers-and-breakthroughs 2026-02-10T13:00:12+00:00 0.5 https://www.iconplc.com/insights/blog/2025/11/24/changing-regulatory-requirements-biosimilar-drug-development-more-nuanced 2026-02-10T13:02:28+00:00 0.5 https://www.iconplc.com/insights/blog/2025/12/01/demographic-matching-organ-impairment-studies 2025-12-04T11:50:28+00:00 0.5 https://www.iconplc.com/insights/blog/2025/12/11/managing-risk-medical-devices 2026-02-10T13:06:32+00:00 0.5 https://www.iconplc.com/insights/blog/2026/01/06/bring-biotechs 2026-02-10T13:15:29+00:00 0.5 https://www.iconplc.com/insights/blog/2026/01/06/2025-awards-and-recognition 2026-02-10T13:11:20+00:00 0.5 https://www.iconplc.com/insights/blog/2026/01/07/mechanism-action-pediatric-research 2026-02-10T13:22:07+00:00 0.5 https://www.iconplc.com/insights/blog/2026/01/09/current-landscape-oncology-rd 2026-02-23T17:12:47+00:00 0.5 https://www.iconplc.com/insights/blog/2026/01/09/enabling-innovation 2026-02-23T09:29:51+00:00 0.5 https://www.iconplc.com/insights/blog/2026/01/13/from-ai-ambition-real-world-impact 2026-02-06T07:50:19+00:00 0.5 https://www.iconplc.com/insights/blog/2026/02/04/connecting-healthcare-data-digital-campaigns-solving-attribution-challenge 2026-02-05T14:54:25+00:00 0.5 https://www.iconplc.com/insights/blog/2026/02/05/managing-ai-model-biases-ai-enabled-samds 2026-02-10T13:47:30+00:00 0.5 https://www.iconplc.com/insights/blog/2026/02/05/advancing-patient-centred-outcomes-sleep-medicine 2026-02-05T13:16:39+00:00 0.5 https://www.iconplc.com/insights/blog/2026/02/19/opportunities-bile-sampling-human-adme 2026-02-23T07:00:23+00:00 0.5 https://www.iconplc.com/insights/blog/2026/03/09/future-clinical-data-science 2026-03-09T14:19:09+00:00 0.5 https://www.iconplc.com/insights/blog/2026/03/12/future-multiple-sclerosis-care 2026-03-18T08:54:36+00:00 0.5 https://www.iconplc.com/insights/blog/2026/03/13/lessons-learned-eu-hta-regulations-first-year 2026-03-16T14:19:49+00:00 0.5 https://www.iconplc.com/insights/blog/2026/03/20/why-incorporating-gmp-and-usp-best-practice-early-phase-trials 2026-03-23T14:38:02+00:00 0.5 https://www.iconplc.com/insights/blog/2026/03/31/framework-pediatric-hrqol-selection 2026-04-01T13:59:24+01:00 0.5 https://www.iconplc.com/solutions/all-case-studies/in-home-services-accelerated-patient-recruitment 2026-02-13T12:34:51+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/blended-solution-gives-emerging-pharma-greater-control-expert-support 2026-02-11T14:36:41+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/strategic-blended-solution-global-upscaling 2026-02-19T14:55:30+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/chinese-sponsor-adopts-blended-delivery-model 2026-02-11T14:58:23+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/partnership-model-evolutions-top-10-pharma-partner 2026-02-16T10:59:22+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/transformation-20-year-partnership 2026-02-20T12:33:50+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/accelerating-car-t-study-start-ups 2026-02-11T12:20:43+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/als-trial-best-practices-ensure-success-amid-recruitment-challenges 2026-02-11T14:10:42+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/streamlining-non-CDISC-dct-data-analysis-reporting 2026-02-19T15:13:42+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/collaborative-approach-advance-early-phase-breast-cancer-research 2026-02-11T15:20:54+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/integrating-safety-and-efficacy-data-submission-analysis 2026-02-13T12:40:56+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/bronchiectasis 2026-02-11T14:42:18+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/cardiovascular-safety-rare-disease-study 2026-02-11T14:55:28+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/seamless-transition-and-lifecycle-management-50-marketed-products 2026-03-27T09:38:37+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/phase-3-unresectable-biliary-tract-carcinoma-study 2026-02-09T15:02:06+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/phase-3-multiple-myeloma-study 2026-02-09T15:05:09+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/high-volume-medical-imaging-support-MASH-trial 2026-02-05T13:28:42+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/success-early-phase-psoriasis-study 2026-02-20T10:54:10+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/transforming-partnership-blended-model 2026-02-20T12:35:29+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/elevating-biopharma-rd-through-multifaceted-support-strategic 2026-02-12T13:52:21+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/driving-high-quality-global-clinical-drug-development 2026-02-12T12:04:28+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/regulatory-resourcing-solution 2026-03-27T09:38:41+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/transitioning-mid-sized-device-company-icon-fsp-model 2026-02-20T12:44:01+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/examining-approved-adult-drugs-kidney-disease-children 2025-12-04T10:16:27+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/strategic-blended-solutions-enterprise-efficiency 2026-02-19T14:57:56+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/icon-leads-portfolio-transition-growth-non-growth-products 2026-03-27T09:38:44+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/technical-evaluations-asset-investment 2026-02-20T12:31:30+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/large-scale-transformation-delivers-lasting-results-clinical-monitoring 2026-02-13T14:43:20+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/strategic-site-management 2026-02-19T15:08:00+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/creating-pool-high-quality-cra-talent 2026-02-12T11:00:50+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/out-performing-ambitions-strategic-capacity-management 2026-02-16T10:27:35+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/cross-functional-partnership 2025-12-04T13:59:51+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/long-term-benefits-embedded-partnerships-biometrics 2025-12-03T15:11:13+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/cardiac-imaging-monitoring-support-PAH-trial 2026-02-11T14:52:49+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/virtual-development-model 2026-02-20T14:11:54+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/growth-through-resource-allocation 2026-02-12T15:06:04+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/data-analytics-enabled-fsp-solutions 2025-12-03T15:05:24+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/vendor-consolidation-top-10-pharma-company 2025-12-03T15:04:21+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/fsp-partnership-sustained-efficiency-and-ongoing-innovation 2026-02-12T14:58:02+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/delivering-high-quality-low-costs 2026-02-12T11:21:57+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/enhancing-strategic-partnerships-through-streamlined-edc-build-processes 2026-02-12T14:08:13+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/comprehensive-due-diligence 2026-02-12T10:23:52+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/prioritising-high-quality-expedited-covid-19-vaccines 2026-02-19T10:29:26+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/due-diligence-portfolio-investments 2026-03-18T14:50:47+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/improved-adherence-high-risk-immunology-study-small-biotech 2026-02-16T13:44:23+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/quantitative-risk-assessments-meet-regulatory-submission-requirements 2026-02-19T11:03:01+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/comprehensive-standalone-dmc-services 2026-02-12T10:26:29+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/patient-support-services 2026-02-16T11:32:19+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/externalised-development-solutions 2026-02-16T14:55:12+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/optimised-adaptive-trial-design-oncology-biotech 2026-02-16T12:23:58+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/crf-design-cell-therapy-immuno-oncology-study 2026-02-17T15:01:22+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/optimising-biosimilar-development 2026-02-16T12:21:02+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/digital-solutions-evolving-covid-19-environment 2026-02-17T14:47:24+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/digital-solutions-reduce-risk-potential-six-study-dermatology-programme 2026-02-17T14:50:11+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/exceeding-expectations-c-diff-vaccine-study 2026-02-16T15:07:36+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/high-performing-sites-cardiovascular-study 2026-02-16T14:43:47+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/overcoming-challenges-covid-19-clinical-trial-conditions 2026-02-16T12:01:15+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/beating-patient-recruitment-target-enhanced-patient-experience 2025-12-03T14:44:03+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/high-performing-sites-during-covid-19-womens-health 2026-02-16T14:42:16+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/agile-operations-drive-enrollment-covid-19-treatment-studies 2026-02-11T14:03:52+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/home-services-patient-centric-practices 2026-02-16T14:30:55+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/patient-recruitment-retention-services 2026-02-16T11:35:31+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/home-services-enhanced-patient-retention 2026-02-16T14:38:04+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/home-services-expanding-geographic-reach 2026-02-16T14:34:42+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/clinical-trial-training-management-system 2026-02-18T09:44:10+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/education-automation 2026-02-17T14:37:02+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/education-automation-reducing-site-burden 2026-02-17T14:34:06+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/large-global-cardiovascular-outcome-program 2026-02-16T13:25:15+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/home-services-improved-site-productivity 2026-02-16T14:32:22+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/home-services-special-populations-and-procedures 2026-02-16T14:24:19+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/overcoming-recruitment-challenges 2026-02-16T11:56:12+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/agile-operations-drive-enrollment-covid-19-treatment-studies-0 2025-12-03T14:24:36+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/patient-insights-strategy 2026-02-16T11:37:32+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/overcoming-challenges-non-small-cell-lung-carcinoma-rescue-study 2026-02-16T11:59:25+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/home-services-patient-satisfaction-levels-rare-disease 2026-02-16T14:29:25+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/home-services-rescue 2026-02-16T14:26:05+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/flexible-and-meticulous-management 2026-02-16T14:52:35+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/home-services-trial-continuity-during-covid-19 2026-02-16T14:13:45+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/overcoming-recruitment-challenges-0 2026-02-16T11:54:09+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/achondroplasia 2025-12-03T14:16:27+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/accelerating-clinical-trial-programs-dermatology 2025-12-03T14:15:13+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/small-biotech-success-story 2026-02-19T14:53:38+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/overcoming-challenges-and-exceeding-recruitment-timeline 2026-02-16T12:02:45+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/rapid-post-market-study-start-up 2026-02-19T11:38:10+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/seamless-transition-pma-post-market-study 2026-02-19T14:34:22+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/volunteer-recruitment-ep-hot-flash-study 2026-02-20T14:17:22+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/hybrid-decentralised-clinical-trial-cell-gene-therapy 2026-02-16T14:08:34+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/fully-decentralised-clinical-trial-heart-failure 2026-02-16T14:47:04+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/hybrid-clinical-trial-model-lupus-nephritis-study 2026-02-16T14:09:59+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/phase-3-primary-immune-thrombocytopenia 2026-02-19T10:10:32+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/successfully-completing-cgt-study-recruitment 2026-02-20T11:11:45+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/rapid-mobilisation-advance-covid-19-vaccine-development 2026-02-19T11:35:28+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/exceeding-recruitment-timelines 2026-02-16T15:00:37+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/h1n1-vaccine-study 2026-02-16T14:45:16+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/human-cytomegalovirus-vaccine-development 2026-02-16T14:11:30+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/leveraging-immuno-oncology-real-world-data 2026-02-16T13:20:27+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/successful-adaptation-complex-dose-escalation 2026-02-20T11:08:00+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/retrospective-chart-review-study-patients-osteoporosis 2026-02-19T13:45:54+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/pku-specific-hrqol-questionnaire-development-validation 2026-02-19T10:20:50+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/rapid-manuscript-development-and-delivery 2026-02-19T11:25:00+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/driving-payer-education-and-awareness 2026-02-17T14:43:45+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/electronic-implementation-and-digital-app-localisation 2026-02-17T14:30:18+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/chronic-myeloid-leukaemia 2025-12-03T12:10:52+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/launching-established-market 2026-02-16T13:22:18+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/language-services-voiceover-and-video-localisation 2026-02-16T13:27:13+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/improving-early-phase-oncology-clinical-trial-design 2026-02-16T13:38:38+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/importance-crf-design-cell-and-gene-therapy-studies 2026-02-16T13:46:53+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/applying-statistical-and-programming 2026-02-11T14:16:35+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/patient-cardiac-safety 2026-02-16T11:40:12+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/evolving-quality-oversight-limit-sponsor-burden 2026-02-16T15:09:44+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/voice-speech-recognition 2026-02-20T14:13:59+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/prioritizing-efficiency-and-fit-purpose-strategy-digital-risk-detection 2026-02-19T10:33:34+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/ivdr-technical-file-remediation 2026-02-16T13:29:12+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/exceeding-recruitment-timelines-double-blind-multiple-system-atrophy-msa 2026-02-16T14:59:09+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/multinational-phase-1-biosimilar-study-biosimilar-product 2026-02-16T12:26:09+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/increased-compliance-complex-alzheimers-disease-study 2026-02-16T13:36:22+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/regulatory-strategy-clinical-development-eu 2026-03-27T09:38:47+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/irt-user-acceptance-testing 2026-02-16T13:31:01+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/proactive-patient-retention-strategy-glp-1-ra-trial 2026-02-19T10:42:40+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/combined-study-vitro-device-investigating-oncology-treatment 2026-03-27T09:38:50+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/clinical-trial-combination-product-and-medical-devices 2026-03-27T09:34:47+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/investigational-new-drug-ind-application 2026-03-27T09:34:50+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/regulatory-guidance-established-products 2026-03-27T09:34:53+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/xevmpdspor-compliance 2026-03-27T09:34:56+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/edms-electronic-document-management-system-expanded-newly-acquired 2026-03-27T09:35:00+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/regulatory-project-management-scenario-planning-oncology 2026-03-27T09:35:02+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/automated-conversion-and-load-including-manual-enrichment 2026-03-27T09:35:05+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/icon-helps-client-achieve-global-expansion-and-reduction-approval 2026-03-27T09:35:09+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/post-marketing-surveillance-studies-korea 2026-02-19T10:23:28+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/team-delivered-initial-us-bla-and-eu-maa-major-amendment 2026-03-27T09:31:46+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/icon-implements-new-lay-protocol-synopsis-lps-program 2026-02-16T14:03:16+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/full-manual-creation-target-source 2026-03-27T09:31:27+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/regulatory-technology-services 2026-03-27T09:31:24+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/pac19-vcn-ddpcr-test 2026-02-16T11:48:32+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/replication-competent-lentiviruses-rcl-qpcr-test 2026-02-19T13:39:19+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/effective-collaboration-clinical-data-standards-governance 2026-02-17T14:32:31+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/prioritising-efficiency-and-flexibility-safety-data-signal-detection 2026-02-19T10:26:35+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/flexible-robust-and-rapid-irt-solution-international-infectious-disease 2026-02-16T14:50:55+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/icon-safety-reporting-solution 2026-02-16T14:01:04+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/accelerating-site-proposal-and-selection 2026-02-11T13:42:04+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/safety-reporting-continuity-protect-patient-safety-and-maintain 2026-02-19T13:51:44+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/high-priority-cardiovascular-study 2026-02-16T14:40:18+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/rapid-iv-formulation-development-fih-adme-study 2026-02-19T11:21:26+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/securing-cra-talent-pipeline-us-pharmaceutical-company 2026-02-19T14:37:03+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/accelerated-auxiliary-medicine-procurement-mash-trial 2026-02-18T10:03:42+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/overcoming-activation-and-enrollment-delays 2026-03-27T09:31:00+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/early-phase-study-non-opioid-pain-treatment 2026-02-17T14:40:38+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/rim-data-and-system-assessment-ensure-idmp-compliance 2026-03-27T09:28:19+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/pivotal-nda-submission-trial-als 2026-02-19T10:15:27+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/pivotal-study-tbi 2026-02-19T10:17:42+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/rapid-mobilisation-advance-covid-19-treatment-development 2026-02-19T11:32:56+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/trial-decentralisation 2026-02-20T13:56:42+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/long-term-follow-study-rare-disease-gene-therapy 2026-02-16T13:12:32+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/complex-early-phase-study-huntingtons-disease 2025-12-03T11:01:25+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/severe-copd-phase-iii-case-study 2026-02-19T14:40:55+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/study-type-1-diabetes-patients 2026-02-20T10:51:02+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/successes-phase-2-autologous-cellular-therapy-oncology-programme 2026-02-20T10:56:58+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/triple-negative-breast-cancer 2026-02-20T13:59:27+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/allergic-rhinitis 2026-01-08T16:25:33+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/pain-proof-concept 2026-02-16T11:46:56+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/enhancing-impact-scientific-posters 2026-02-17T13:50:17+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/automating-edc-user-access-improved-trial-efficiency 2026-02-18T09:54:45+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/re-adjudicating-respiratory-and-cardiovascular-trial-during-covid-19 2026-02-19T11:43:38+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/exceeding-late-phase-study-recruitment-goals 2026-02-16T15:02:14+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/building-scalable-partnership-model-accelerate-biopharma-innovation 2026-02-11T14:49:54+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/exceeding-expectations-late-stage-rescue-study-success 2026-02-16T15:04:48+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/protocol-optimisation 2026-02-19T10:49:42+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/optimising-site-selection-rescue-study 2026-02-16T12:16:59+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/eliminating-enrolment-delays-bring-ai-enabled-samd-market 2026-03-27T09:28:23+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/extensive-patient-access-and-recruitment-strategies 2026-02-16T14:56:55+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/affiliate-level-solution 2026-02-11T14:00:49+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/complex-phase-1-obesity-study 2026-03-10T15:43:06+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/overcoming-enrollment-challenges-early-phase-obesity-trial 2026-02-16T11:57:52+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/cmc-and-local-regulatory-expertise-deliver-timely-anti-cancer-drug 2026-03-27T09:28:26+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/seamless-transition-functional-service-provider-medical-writing 2026-02-19T14:29:58+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/overcoming-time-zone-and-knowledge-gaps-gain-fda-ind-study-approval 2026-03-27T09:28:29+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/custom-fsp-model-drives-sponsor-success 2025-12-03T10:35:47+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/reducing-time-and-cost-curve 2026-02-19T11:51:45+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/use-real-world-data-fulfil-post-approval-requirements 2026-03-27T09:22:06+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/regulatory-solutions-uncharted-scientific-waters 2026-03-27T09:21:28+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/regulatory-problem-solving-secures-crucial-extensions-pediatrics-and 2026-03-27T09:21:02+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/optimising-resources-portfolio-large-scale-oncology-studies 2026-02-16T10:22:34+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/overcoming-under-enrolment-assay-study-neonate-sepsis 2026-02-16T11:50:46+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/immune-assay-thyroid-diseases 2026-02-16T13:51:01+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/resolving-patient-recruitment-issues-oncology-study 2026-02-19T13:43:21+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/collaborating-improve-monitoring-visit-trip-reports 2026-02-18T09:34:56+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/ensuring-consistent-source-data-monitoring-global-cardiology-study 2026-02-16T15:22:40+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/enabling-asian-biotech-enter-us-and-eu-markets-rare-neurodegenerative 2026-03-27T09:20:44+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/meeting-new-rems-spl-guidelines-22-months-they-became-mandatory 2026-03-27T09:19:22+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/partnering-provide-vital-regional-support-global-medical-device-study 2026-02-16T11:44:14+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/scaling-optimised-global-vaccine-trial-flexible-fsp 2026-02-19T14:14:33+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/symphony-health-and-dentsu-health-partner-reach-rare-disease-patients 2026-02-20T11:20:02+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/breakthrough-patient-reach 2026-02-18T09:47:34+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/driving-better-outcomes-innovative-interventions 2026-03-19T12:13:07+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/privacy-safe-high-performing-digital-campaign-targeting 2026-02-19T10:37:59+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/accelerating-team-growth-support-client-demand 2026-02-11T13:53:57+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/line-therapy-analysis-support-commercialisation-efforts-rare-disease 2026-02-16T13:16:19+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/leveraging-real-world-data-and-machine-learning 2026-02-16T13:18:05+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/disparities-access-branded-migraine-therapies 2026-02-17T14:45:58+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/using-rwe-differentiate-tyk2-inhibitors-crowded-psoriasis-market 2026-02-20T14:07:11+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/quantifying-impact-sdoh 2026-02-19T10:57:43+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/achieving-highly-accurate-social-media-measurement 2026-02-11T13:56:31+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/regulatory-support-asian-biotechs-eu-orphan-drug-designation 2026-03-27T09:18:03+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/strategic-problem-solving-complex-canadian-new-drug-submission 2026-03-27T09:18:47+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/creating-roadmap-growth-blood-products-company 2026-03-27T09:17:04+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/streamlining-clinical-operations 2026-02-19T15:11:02+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/monoclonal-antibody-drug-development 2026-02-16T12:30:54+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/targeted-engagement-global-multi-functional-collaboration 2026-02-20T12:24:10+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/strategic-expansion-clinical-operations-support-and-tmf-hub 2026-02-19T15:00:57+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/site-strategy-and-endpoint-integrity-drive-hcm-trial-success 2026-02-19T14:50:53+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/coordinating-multi-region-diabetes-comparators 2026-02-10T10:45:10+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/accelerating-study-start-through-unit-based-stand-alone-model 2026-01-16T08:57:58+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/accelerating-site-activation-over-50 2026-02-10T10:48:06+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/custom-framework-consistent-compliant-global-labelling 2026-02-17T14:56:53+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/accelerating-study-start-through-standardised-irt-integration 2026-02-11T13:47:05+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/supporting-anda-submission-drug-device-product 2026-03-24T15:10:12+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/impact-point-care-marketing-hospital-settings 2026-02-16T13:49:06+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/early-engagement-award 2026-02-17T14:42:08+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/integration-multiple-oncology-studies-single-ole-study 2026-02-16T13:34:30+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/consolidation-multiple-protocols-single-lte-oncology-study 2026-02-12T10:30:45+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/rapid-deployment-compassionate-use-program 2026-02-19T11:08:02+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/transitioning-phase-3-study-eap 2026-02-20T13:51:02+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/blended-fsp-fso-model-powers-global-expansion-chinese-biotech 2026-02-18T09:53:57+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/delivering-quality-data-and-98-retention-rate-biosimilar-study 2026-02-17T14:52:43+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/imaging-process-boosts-efficiency-oncology-device-trial 2026-02-16T13:58:40+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/streamlining-participant-enrolment-address-cohort-specific-shortfalls 2026-02-20T10:47:29+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/improving-compliance-alzheimers-disease-dct 2026-03-12T13:09:09+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/reducing-participant-burden-vms-study 2026-02-19T11:48:54+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/more-patients-enrolled-faster-fewer-sites 2026-02-16T12:28:47+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/scaling-safety-operations-first-market-launch 2026-02-23T09:28:27+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/saving-lean-biotech-more-4-million-strategic-regulatory-support 2026-03-24T15:09:33+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/decade-long-partnership-driving-etmf-hub-expansion 2026-02-17T14:54:54+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/collaboration-accelerates-rare-disease-trial-delivery 2026-03-19T11:23:55+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/transforming-post-marketing-safety-operations 2026-02-20T12:40:09+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/wearables-and-remote-monitoring-case-study 2026-02-20T14:31:30+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/understanding-breast-cancer-patient-journey 2026-01-30T15:20:18+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/navigating-complexity-achieve-clinical-trial-success 2026-02-19T11:47:56+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/driving-data-excellence-across-global-rd-portfolio 2026-02-24T11:15:23+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/icons-system-driven-data-validation-tool 2026-03-24T15:09:03+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/successfully-completing-recruitment-early-alzheimers-disease-study 2026-03-11T11:47:44+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/optimising-fully-decentralised-alzheimers-study 2026-03-13T07:13:26+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/ensuring-protocol-compliance-alzheimers-study 2026-03-12T13:07:23+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/navigating-consent-regulatory-requirements-and-data-challenges-multi 2026-03-17T09:29:32+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/streamlining-global-budget-development-negotiation 2026-03-19T08:08:47+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/country-box-clinical-trial-delivery-across-emerging-countries 2026-04-01T15:33:09+01:00 0.5 https://www.iconplc.com/news-events/events/webinars/a-novel-approach-to-als-trial-development 2026-02-06T08:55:51+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/a-strategic-technology-driven-approach 2025-12-15T13:50:27+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/acc-icer-report-impact 2026-02-10T15:27:22+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/activity-monitoring-setting-standards 2025-12-15T14:11:07+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/advancements-in-ai-for-optimal-clinical-trial-site-identification 2025-12-15T14:12:27+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/an-introduction-to-infectious-disease-modelling 2025-12-15T14:14:01+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/an-overview-of-drug-development-strategy 2025-12-15T14:15:15+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/antimicrobial-resistance 2025-12-15T14:16:32+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/applying-the-latest-digit 2026-02-11T10:37:11+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/approach-to-career-profes 2025-12-15T14:20:40+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/approach-to-diversity-assessment 2025-12-15T14:27:53+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/artificial-intelligence 2026-03-23T15:05:51+00:00 0.5 https://www.iconplc.com/news-events/events/webinar/atmps-hta-pricing 2026-02-10T15:20:34+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/best-practice-in-cgt-lab-solutions 2025-12-15T14:29:26+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/best-practices-in-seasonal-vaccine-studies 2026-02-11T10:44:08+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/beyond-the-token 2025-12-15T14:31:07+00:00 0.5 https://www.iconplc.com/news-events/events/webinar/bring-your-own-device-byod-ecoa 2025-12-11T08:25:04+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/cardiovascular-event-adjudication-during-covid-19 2026-02-11T10:51:49+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/cell-and-gene-therapies-d 2026-02-11T10:54:29+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/challenges-in-assessing-l 2025-12-15T17:23:59+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/clinical-outcomes 2025-12-11T08:25:04+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/clinical-trial-computerised-systems-and-electronic-data 2025-12-11T08:25:12+00:00 0.5 https://www.iconplc.com/news-events/events/webinar/clinical-trial-diversity-post-pandemic-world 2026-03-26T12:26:58+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/clinical-trials-in-china 2025-12-15T17:25:58+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/cns-imaging 2026-02-11T11:04:34+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/conducting-clinical-trial 2025-12-11T08:25:12+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/cross-cultural-differences-in-coa-translations 2025-12-15T17:48:58+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/database-mapping 2026-02-11T11:08:21+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/dct-in-focus 2025-12-11T08:25:12+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/dct-operational-best-practices 2025-12-15T17:51:22+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/DCT-regulatory-and-legal-considerations-for-clinical-data 2025-12-15T17:52:30+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/designing-and-conducting 2026-02-11T11:12:00+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/developing-an-obsro 2025-12-15T17:56:11+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/development-validation-of-clinros 2025-12-15T18:05:40+00:00 0.5 https://www.iconplc.com/news-events/events/webinar/digital-endpoint-strategy-and-validation 2026-02-10T15:25:54+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/digital-solutions-to-alleviate-nash-clinical-trial-challenges 2025-12-16T11:23:10+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/disrupting-traditional-clinical-research-with-dct 2025-12-16T11:26:41+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/effective-ingestion-and-normalization-of-real-world-data-sources 2026-02-11T11:16:59+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/electronic-health-records 2025-12-16T11:47:58+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/engagement-and-retention-of-patients-in-rare-orphan-disease-clinical-trials 2026-02-11T11:21:23+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/engaging-physicians-in-a 2025-12-16T11:54:11+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/estimands-and-sensitivity-analyses-in-clinical-trials 2026-02-11T11:26:08+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/evidence-synthesis-for-sparse-evidence-base-heterogeneous-studies-and-disconnected-networks 2025-12-16T12:03:05+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/exploring-outsourcing-mod 2025-12-11T08:25:12+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/exploring-outsourcing-models-through-a-partnership-lens 2025-12-16T12:04:11+00:00 0.5 https://www.iconplc.com/news-events/events/webinar/hot-flashes-brain-fog-and-blues-frontiers-menopause-treatments 2025-12-11T08:25:12+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/he-assessments-in-france 2026-02-11T11:28:15+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/helping-nash-study-sites 2026-02-11T11:30:25+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/hiv-treatments 2026-02-23T11:59:41+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/home-health-best-practice 2025-12-16T13:41:45+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/how-icon-is-transforming-clinical-trial-processes-with-RPA 2026-02-23T12:05:40+00:00 0.5 https://www.iconplc.com/news-events/events/webinar/how-ensure-compliance-new-eu-medical-device-regulations 2026-02-26T15:33:57+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/how-to-increase-engagement-with-medical-and-scientific-posters 2025-12-16T13:46:03+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/how-to-take-your-imaging-trials-to-the-next-level-with-automation 2025-12-11T08:25:20+00:00 0.5 https://www.iconplc.com/news-events/events/webinar/icons-world-childrens-day 2025-12-11T08:25:20+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/impact-of-fdas-recent-guidance-on-payer-communications 2025-12-16T13:49:49+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/implementing-novel-development-strategies-for-cgt-clinical-trials 2026-02-23T12:14:46+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/improving-patient-adherence-with-game-design 2025-12-16T17:14:11+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/improving-r-and-d-efficiency-through-a-holistic-approach-to-clinical-trials 2025-12-11T08:25:20+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/integrating-qualitative-patient-interviews-into-a-clinical-trial-protocol 2026-02-23T12:27:28+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/isct-patient-advocacy 2025-12-16T17:28:12+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/ispor-webinar-improving-performance-selection-and-development-of-perfo-assessments 2025-12-11T08:25:20+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/keep-ecoa-off-the-critical-path 2025-12-16T17:29:47+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/keeping-your-trial-on-tra 2026-02-23T12:32:28+00:00 0.5 https://www.iconplc.com/news-events/events/webinar/fda-waivers-tqt-studies 2025-12-11T08:25:20+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/leveraging-smartphone-sensors 2025-12-16T17:31:06+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/linguistic-validation 2025-12-16T17:43:10+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/linking-evidence-and-value-strategies 2025-12-16T17:48:36+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/market-access-hurdles 2025-12-16T17:50:59+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/medicare-part-d-price-negotiation-panel-discussion 2025-12-11T08:25:20+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/nash-clinical-trials-challenges-and-considerations 2026-02-23T13:42:58+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/navigating-the-future-of-cgt 2026-02-23T13:44:50+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/navigating-the-new-eu-ctr-regulations 2025-12-16T21:11:44+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/navigating-the-new-normal-during-covid-19 2025-12-11T08:25:29+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/oncological-imaging 2025-12-16T21:12:41+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/open-source-toolkit-for-c 2025-12-16T21:15:14+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/optimise-medical-publishing 2025-12-16T21:17:33+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/optimise-your-regulatory-submissions 2026-02-06T08:47:33+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/optimise-your-rwe-investments 2025-12-16T21:23:27+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/outcomes-based-agreements 2025-12-16T21:25:15+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/overcoming-5-barriers-to-harmonised-rwd 2026-02-23T13:50:44+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/payer-perspectives-on-digital-therapeutics 2025-12-16T21:27:25+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/pediatric-considerations 2025-12-16T21:28:52+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/perinatal-mood-disorders 2025-12-16T21:30:12+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/pharma-cros-on-modernizin 2025-12-16T21:38:12+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/pharmacovigilance-and-pat 2025-12-16T21:46:25+00:00 0.5 https://www.iconplc.com/news-events/events/webinar/pharmacovigilance-apac 2025-12-11T08:25:29+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/physical-performance-outcomes 2025-12-17T10:43:46+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/qualitative-longitudinal-1 2026-02-23T13:58:39+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/quality-cell-and-gene-therapies-through-multidisciplinary-collaboration 2026-02-23T14:08:41+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/r-shiny 2026-02-16T07:29:34+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/rare-disease-dei 2025-12-11T08:25:29+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/rare-disease-registry-and 2025-12-17T14:02:31+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/rare-disease-week-2023/accessibility-in-rare-disease-paediatric-clinical-trials 2026-02-23T14:13:40+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/rare-disease-week-2023/best-practices-in-accessible-clinical-trial-design 2026-02-23T14:15:40+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/rare-disease-week-2023 2026-03-26T12:28:59+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/rare-disease-week-2023/is-disability-part-of-you-dei-planning-and-engagement 2026-02-23T14:17:29+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/rare-disease-week-2023/meeting-trial-participants-where-they-are-at 2026-02-23T14:19:33+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/rare-disease-week-2023/not-all-measures-matter 2026-02-23T14:21:34+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/rare-disease-week-2023/speakers-bios 2026-02-23T14:22:59+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/rare-disease-week-2023/unique-considerations-around-accessibility-for-global-clinical-trials 2026-02-23T14:24:23+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/rare-disease-week-2023/where-do-expanded-access-programs-fit-into-trial-accessibility 2026-02-23T14:25:40+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/rare-diseases-natural-history-studies-for-drug-development 2025-12-17T15:12:46+00:00 0.5 https://www.iconplc.com/news-events/events/webinar/reflections-paediatric-assent 2025-12-11T08:25:29+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/regulatory-and-legal-cons-1 2025-12-17T15:18:19+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/resilient-clinical-trials-decentralising-and-digitising 2025-12-17T15:21:57+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/rwe-across-the-product-lifecycle 2018-05-30T22:50:55+01:00 0.5 https://www.iconplc.com/news-events/events/webinars/social-media-data-opportunities-and-insights 2025-12-17T15:30:40+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/studies-with-13c-and-14c-labeled-investigational-medicinal-products 2026-01-20T12:28:29+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/survival-analysis-in-hta 2020-04-09T21:17:47+01:00 0.5 https://www.iconplc.com/news-events/events/webinars/technology-solutions-late-phase 2025-12-11T08:25:29+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/the-changing-face-of-cell 2026-02-23T14:27:23+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/the-developing-hta-landscape-in-apac 2026-02-23T14:32:38+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/the-importance-of-early-planning-for-cgt-commercialisation 2026-02-23T14:38:02+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/the-new-world-of-drug-safety 2026-02-11T11:37:43+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/the-rare-disease-revolution 2018-01-25T12:39:00+00:00 0.5 https://www.iconplc.com/news-events/events/webinar/webinar-template-successful-digital-trial 2023-10-25T13:56:09+01:00 0.5 https://www.iconplc.com/news-events/events/webinars/understanding-health-care-decision-maker-preferences-for-optimised-engagement 2025-12-17T16:04:06+00:00 0.5 https://www.iconplc.com/news-events/events/webinar/unlocking-potential-clinical-trial-tokenisation 2025-12-17T16:08:57+00:00 0.5 https://www.iconplc.com/news-events/events/webinar/using-early-economic-models-developing-your-evidence-strategy 2025-12-11T08:25:29+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/using-early-scientific-advice-in-drug-development 2026-02-11T11:42:36+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/using-external-control-arm-studies-in-HTA-submissions 2026-02-23T14:59:58+00:00 0.5 https://www.iconplc.com/news-events/events/webinar/using-historical-controls-rare-disease-clinical-trials 2025-12-11T08:25:29+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/using-wearables-data-to-support-reimbursement 2026-02-23T15:06:34+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/vaccine-research-in-a-pos 2025-12-17T16:35:55+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/value-of-early-phase-medical-communication-planning 2025-12-17T16:38:45+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/webinar-advocating-for-yo 2025-12-17T16:41:06+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/whats-next-in-ecoa 2018-05-30T22:50:56+01:00 0.5 https://www.iconplc.com/news-events/events/webinars/women-in-pharma_navigatin 2025-12-17T16:48:50+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/world-childrens-day 2025-12-11T08:25:29+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/best-practices-for-the-validation-of-hybrid-lc-ms-ms-assays 2025-12-11T08:25:38+00:00 0.5 https://www.iconplc.com/news-events/events/webinar/overview-global-operational-best-practices-successful-delivery-cell-gene 2025-12-11T08:25:38+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/streamlining-irt-clinical-trials-simplify-optimise-succeed 2025-12-11T08:25:38+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/strategies-optimise-commercialisation-oncology-treatments-younger-adults 2025-12-11T08:25:38+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/future-pharmacovigilance-exploring-automation-and-ai-literature 2025-12-11T08:25:38+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/navigating-complexity-real-world-healthcare-data-choosing-right-tools 2025-12-11T08:25:38+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/ai-and-adverse-event-literature-detection-post-market-surveillance 2025-12-11T08:25:38+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/practical-guidance-successful-global-regulatory-submissions 2025-12-11T08:25:38+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/ensuring-patient-recruitment-success-site-level 2025-12-11T08:25:38+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/rare-disease-week-2024 2025-12-11T08:25:38+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/rare-disease-week-2024/future-trends-in-rare-disease-drug-dev 2025-12-11T08:25:48+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/rare-disease-week/no-patient-left-behind 2025-12-11T08:25:48+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/rare-disease-week-2024/equity-and-access-in-rare-disease-trials 2025-12-11T08:25:48+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/strategic-approaches-first-human-fih-studies-and-early-clinical 2025-12-11T08:25:48+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/unlocking-precision-medicine-overview-illuminas-tso500 2026-01-08T09:57:32+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/mastering-rmps-and-rmms-tech-driven-solutions-patient-safety 2025-12-11T08:25:48+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/regulatory-submission-writing-nda-success 2025-12-11T08:25:48+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/artificial-intelligence-clinical-research 2025-12-11T08:25:48+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/singlicate-ada-analysis 2025-12-11T08:25:48+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/survival-analysis-immature-data-review-techniques-and-lessons-learned 2025-12-11T08:25:48+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/considerations-oligonucleotide-therapeutics-cmc 2025-12-11T08:25:57+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/fda-guidance-use-data-monitoring-committees-clinical-trials 2025-12-11T08:25:57+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/medicare-part-d-price-negotiation-update 2025-12-11T08:25:57+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/continuous-long-term-cardiovascular-monitoring-clinical-trials 2025-12-11T08:25:57+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/panel-discussion-immunogenicity-assessment-therapeutic-proteins 2025-12-11T08:25:57+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/dosimetry-clinical-trials 2025-12-11T08:25:57+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/unlocking-strategies-with-regulatory-translation-management 2025-12-11T08:25:57+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/strategic-approaches-first-human-fih-studies-and-early-clinical-0 2025-12-11T08:25:57+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/s-stands-systematic-demystifying-systematic-literature-review 2025-12-11T08:25:57+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/clinical-outcome-assessments-clinical-trials-how-secure-permission-use 2025-12-11T08:25:57+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/pregnant-participants-clinical-trials 2025-12-11T08:26:06+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/implementing-digital-health-technologies-patient-centred-trials 2025-12-11T08:26:06+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/strategies-adc-bioanalysis 2025-09-30T06:22:30+01:00 0.5 https://www.iconplc.com/news-events/events/webinars/joint-clinical-assessment-2025 2025-10-02T17:24:56+01:00 0.5 https://www.iconplc.com/news-events/events/webinars/addressing-orphan-and-rare-diseases-cutting-edge-conversation 2025-12-11T08:26:06+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/panel-discussion-adc-bioanalytics 2025-12-11T08:26:06+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/get-ready-new-wave-clinical-trials-schizophrenia 2025-12-11T08:26:06+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/deep-dive-into-claims-data-innovation 2025-06-25T12:27:01+01:00 0.5 https://www.iconplc.com/news-events/events/webinars/unlocking-biotech-value 2025-12-15T13:26:29+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/network-meta-analysis-and-its-role-evidence-based-decision-making 2025-12-11T08:26:06+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/pediatric-risk-assessment-map 2025-12-15T13:25:20+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/introducing-icon-strategic-solutions-fsp-services-how-model-supports 2025-12-11T08:26:06+00:00 0.5 https://www.iconplc.com/news-events/events/industry/scdm-india-1 2025-11-26T09:37:36+00:00 0.5 https://www.iconplc.com/news-events/events/industry/ash 2025-08-06T14:37:57+01:00 0.5 https://www.iconplc.com/news-events/events/industry/global-cvct 2025-08-06T14:39:57+01:00 0.5 https://www.iconplc.com/news-events/events/webinars/boosting-clinical-trial-success-alzheimers-parkinsons-and-other 2025-10-28T08:38:51+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/enhancing-clinical-trials-obesity-integrating-clinical-outcome 2025-12-11T08:26:06+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/pivotal-trial-design-considerations-new-and-next-generation-cell-and 2025-12-11T08:26:09+00:00 0.5 https://www.iconplc.com/news-events/events/industry/cphi 2026-02-23T15:09:42+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/beyond-bench-advantages-gmp-over-usp-compounding-early-phase 2025-11-13T13:05:50+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/strategic-approaches-early-clinical-trials-neurodegenerative-diseases 2025-11-24T09:54:47+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/riding-data-wave-how-pharma-can-navigate-disruptions-open-claims 2025-12-16T13:23:40+00:00 0.5 https://www.iconplc.com/news-events/events/industry/science-tap 2025-12-09T12:01:10+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/becoming-sponsor-choice-high-performing-sites 2025-12-15T13:24:29+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/ich-gcp-e6r3-preparing-global-implementation 2026-02-23T15:14:04+00:00 0.5 https://www.iconplc.com/news-events/events/industry/jp-morgan-health 2025-11-26T09:52:44+00:00 0.5 https://www.iconplc.com/news-events/events/industry/biotech-showcase-0 2025-11-26T09:52:27+00:00 0.5 https://www.iconplc.com/news-events/events/workshop/new-and-advanced-features-nonmem-76-workshop-0 2025-12-12T12:19:23+00:00 0.5 https://www.iconplc.com/news-events/events/industry/amcp 2026-01-08T11:47:00+00:00 0.5 https://www.iconplc.com/news-events/events/industry/wrib 2026-02-06T07:50:26+00:00 0.5 https://www.iconplc.com/news-events/events/industry/glp-1-based-therapeutics-summit 2026-03-12T11:17:04+00:00 0.5 https://www.iconplc.com/news-events/events/industry/cto-west-coast 2026-03-17T10:59:36+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/when-patients-lead 2026-03-09T16:08:09+00:00 0.5 https://www.iconplc.com/news-events/events/industry/european-heart-rhythm-association 2026-04-01T10:04:56+01:00 0.5 https://www.iconplc.com/news-events/events/industry/scdm-emea 2026-03-04T09:59:34+00:00 0.5 https://www.iconplc.com/news-events/events/industry/raps-euro-convergence 2026-01-26T12:35:25+00:00 0.5 https://www.iconplc.com/news-events/events/industry/oct-europe 2026-01-26T12:38:01+00:00 0.5 https://www.iconplc.com/news-events/events/industry/bio-middle-east 2026-01-26T12:43:24+00:00 0.5 https://www.iconplc.com/news-events/events/industry/aaps-nbc 2026-02-06T07:50:46+00:00 0.5 https://www.iconplc.com/news-events/events/industry/oct-east-coast 2026-03-26T14:48:31+00:00 0.5 https://www.iconplc.com/news-events/events/industry/dia-china 2026-03-04T10:01:22+00:00 0.5 https://www.iconplc.com/news-events/events/industry/ispor-us 2026-01-26T12:58:38+00:00 0.5 https://www.iconplc.com/news-events/events/industry/asco 2026-01-26T13:11:36+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/best-practices-global-flow-cytometry-quality-control-and-harmonisation 2026-02-09T11:58:40+00:00 0.5 https://www.iconplc.com/news-events/events/workshop/beginnersintermediate-online-nonmempdx-pop-workshop 2026-02-10T07:52:43+00:00 0.5 https://www.iconplc.com/news-events/events/workshop/advanced-online-nonmempdx-pop-workshop 2026-02-10T07:57:46+00:00 0.5 https://www.iconplc.com/news-events/events/industry/17th-open-scientific-eip-symposium-immunogenicity-biopharmaceuticals 2026-03-12T10:59:41+00:00 0.5 https://www.iconplc.com/news-events/events/webinars/flow-cytometry-bioanalysis 2026-04-01T06:50:28+01:00 0.5 https://www.iconplc.com/news-events/events/industry/pharmasug-india-single-day-event 2026-03-10T11:41:50+00:00 0.5 https://www.iconplc.com/news-events/events/industry/bio-korea 2026-04-01T12:34:19+01:00 0.5 https://www.iconplc.com/news-events/press-releases/41st-annual-jp-morgan 2025-12-18T06:58:00+00:00 0.5 https://www.iconplc.com/news-events/press-releases/acquisition-clinical-research-management 2025-12-18T06:57:04+00:00 0.5 https://www.iconplc.com/news-events/press-releases/acquisition-medimedia 2025-04-23T15:56:53+01:00 0.5 https://www.iconplc.com/news-events/press-releases/acquisition-of-medinova-research 2026-02-23T15:19:19+00:00 0.5 https://www.iconplc.com/news-events/press-releases/award-win-pharma-times 2025-12-18T06:55:43+00:00 0.5 https://www.iconplc.com/news-events/press-releases/barda-anthrax-vaccine-clinical-trial 2026-02-24T12:36:38+00:00 0.5 https://www.iconplc.com/news-events/press-releases/barda-reselects-icon-as-preferred-partner 2026-02-06T08:32:08+00:00 0.5 https://www.iconplc.com/news-events/press-releases/best-cro-scrip-awards 2026-02-06T08:28:13+00:00 0.5 https://www.iconplc.com/news-events/press-releases/best-cro-world-vaccine-congress 2025-04-23T15:32:21+01:00 0.5 https://www.iconplc.com/news-events/press-releases/clinical-research-team-award 2025-12-18T06:53:44+00:00 0.5 https://www.iconplc.com/news-events/press-releases/covid-19-vaccines 2025-12-18T06:52:44+00:00 0.5 https://www.iconplc.com/news-events/press-releases/credit-rating 2025-12-18T06:51:55+00:00 0.5 https://www.iconplc.com/news-events/press-releases/elearning-and-animation-awards 2025-12-18T06:51:24+00:00 0.5 https://www.iconplc.com/news-events/press-releases/firecrest-pre-screen-launch 2025-12-18T06:50:39+00:00 0.5 https://www.iconplc.com/news-events/press-releases/forbes-names-icon-in-list-of-best-employers-in-america-for-women-2020 2025-04-23T13:48:00+01:00 0.5 https://www.iconplc.com/news-events/press-releases/forbes-names-icon-in-list-of-best-employers-in-america-for-women 2025-04-23T12:33:06+01:00 0.5 https://www.iconplc.com/news-events/press-releases/forbes-names-icon-one-of-the-best-employers-in-america 2026-02-24T12:52:32+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-acquires-mapi-group 2026-02-06T08:25:21+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-acquires-medpass-international 2026-02-24T13:03:37+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-acquires-molecularmd 2026-02-24T13:15:23+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-acquires-pmg-research 2025-12-18T06:47:49+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-acquiring-clinical-research 2025-12-18T06:47:08+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-and-amag-pharmaceutical-honoured 2025-04-23T14:51:06+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-announces-appointment-to-board-of-directors 2025-04-23T14:31:52+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-announces-clinical-research-partnership-with-dupage-medical-group 2025-04-23T14:48:58+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-announces-the-expansion-of-its-accellacare-site-network 2025-12-18T06:44:47+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-best-employers-in-america 2025-04-23T15:31:21+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-cares-esg-report 2025-12-18T06:43:15+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-establishes-university-scholarship-program-for-underrepresented-groups 2025-12-18T06:42:19+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-fourth-quarter-2017-results 2025-04-23T14:54:53+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-issues-financial-guidance-for-full-year-2022 2025-12-18T06:39:07+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-issues-financial-guidance-for-full-year-2023 2025-12-17T14:52:44+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-launches-accellacare-a-global-clinical-research-network 2026-03-26T12:25:53+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-launches-firecrest-financial-disclosure 2025-04-23T14:47:17+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-launches-firecrest-safety-letters-and-site-question-management 2025-12-17T14:51:33+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-launches-new-patient-engagement-portal 2026-02-24T15:28:41+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-launches-the-coronavirus-observatory 2026-02-25T10:21:13+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-named-best-contract-research-organisation-2021 2025-12-16T08:38:50+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-named-business-finance-company-of-the-year-and-one-of-forbes-best-employers-for-diversity 2025-12-16T08:38:24+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-named-by-forbes-as-one-of-the-best-employers-in-america 2025-12-16T08:37:57+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-pfizer-biontech 2026-02-25T10:36:14+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-plc-schedules-second-quarter-2022-earnings-conference-call 2025-12-16T08:34:57+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-plc-set-to-join-russell 2025-12-16T08:31:14+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-receives-2018-cro-ph 2025-12-16T08:30:42+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-recognised-as-leading-CRO 2025-12-16T08:25:30+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-recognised-for-cro-excellence 2025-12-16T08:24:59+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-releases-environmental-social-and-governance-report 2025-12-16T08:23:36+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-releases-first-environmental-social-and-governance-report 2025-12-16T08:19:50+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-releases-its-2021-esg-report 2025-12-16T07:59:09+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-releases-latest-version-of-its-digital-platform 2025-12-16T07:59:57+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-reports-first-quarter-2020-results 2025-12-16T07:58:46+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-reports-first-quarter-2021-results 2025-12-16T07:58:17+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-reports-first-quarter-2022-results 2025-12-16T07:57:31+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-reports-first-quarter-2023-results 2025-12-16T07:57:07+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-reports-fourth-quarter-and-full-year-2019-results 2025-12-16T07:56:43+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-reports-fourth-quarter-and-full-year-2020-results 2025-12-16T07:56:17+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-reports-fourth-quarter-and-full-year-2021-results 2025-12-16T07:55:49+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-reports-fourth-quarter-and-full-year-2022-results 2025-12-16T07:55:18+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-reports-second-quarter-2021-results 2026-02-05T13:50:10+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-reports-second-quarter-2022 2025-12-15T15:08:30+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-reports-second-quarter-2023-results 2025-12-15T15:08:11+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-reports-third-quarter-2020-results 2025-12-15T15:07:49+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-reports-third-quarter-2021-results 2026-02-05T13:49:30+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-reports-third-quarter-2022 2025-12-15T15:07:08+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-schedules-fourth-quarter2022-earnings-conference-call 2025-12-15T15:06:29+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-schedules-second-quarter-2023-earnings-conference-call 2025-12-15T14:25:05+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-schedules-third-quarter-2023-earnings-conference-call 2025-12-15T14:24:37+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-shareholders-vote-in-1 2025-12-15T14:24:13+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-shareholders-vote-in-favour-of-all-resolutions-at-agm 2025-12-15T14:23:45+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-shareholders-vote-in-favour-of-all-resolutions-at-its-annual-general-meeting 2025-12-15T14:22:28+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-shareholders-vote-in-favour-of-resolutions-at-agm 2025-12-15T14:21:55+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-signs-new-service-agreement-with-pfizer 2025-12-15T14:21:18+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-to-acquire-medimedia 2025-12-15T14:17:34+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-to-acquire-pra-health-sciences 2025-12-15T14:14:16+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-to-present-at-upcoming-investor-conferences 2025-12-15T14:13:09+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-tokenisation-release 2025-12-15T14:12:50+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-uk-gender-pay-gap-report-2018 2025-12-15T14:12:22+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-win-best-contract-research-organisation-at-scrip-awards-2019 2025-12-15T14:11:34+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-wins-best-cro-at-the-vaccines-industry-excellence-awards 2025-12-15T14:11:07+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-wins-multiple-care-awards 2026-03-05T12:25:38+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-wins-multiple-categories-in-2019-cro-leadership-awards 2025-12-15T14:10:14+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-wins-multiple-categories-in-2020-cro-leadership-awards 2025-12-15T13:55:19+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-wins-multiple-categories-in-2021-cro-leadership-awards 2025-12-15T13:54:51+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-wins-pharma-contract 2025-12-15T13:54:13+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icons-acquisition-of-symphony-clinical-research 2026-02-25T11:11:19+00:00 0.5 https://www.iconplc.com/news-events/press-releases/launch-of 2025-12-15T13:44:18+00:00 0.5 https://www.iconplc.com/news-events/press-releases/LEO-Pharma-and-ICON-enter-a-strategic-partnership 2025-12-15T13:43:58+00:00 0.5 https://www.iconplc.com/news-events/press-releases/medimedia-managed-markets 2026-02-16T07:30:20+00:00 0.5 https://www.iconplc.com/news-events/press-releases/new-drug-safety-reporting-solution 2025-12-15T13:43:00+00:00 0.5 https://www.iconplc.com/news-events/press-releases/q3-2022-earnings-conference-call 2025-12-15T13:41:25+00:00 0.5 https://www.iconplc.com/news-events/press-releases/research-and-development-support-to-accelerate-decentralised-clinical-trial-technology 2025-12-15T13:41:04+00:00 0.5 https://www.iconplc.com/news-events/press-releases/traumatic-brain-injury-study 2025-12-15T13:39:36+00:00 0.5 https://www.iconplc.com/news-events/press-releases/voice-assistant-applications 2026-02-25T11:32:53+00:00 0.5 https://www.iconplc.com/news-events/press-releases/win-irish-business-awards 2025-12-15T13:38:38+00:00 0.5 https://www.iconplc.com/news-events/press-releases/win-pharma-industry-awards 2025-12-15T13:38:10+00:00 0.5 https://www.iconplc.com/news-events/press-releases/world-leading-healthcare-intelligence-and-clinical-research-organisation 2026-02-05T13:46:49+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-reports-third-quarter-2023-financial-results 2025-12-15T13:34:10+00:00 0.5 https://www.iconplc.com/node/39171 2025-12-15T13:31:24+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-industry-accolades-time-magazine-forbes-financial-times-2023 2025-12-15T13:30:54+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-plc-to-present-at-the-42nd-annual-jp-morgan-healthcare-conference 2025-12-15T13:30:21+00:00 0.5 https://www.iconplc.com/news-events/press-releases/biotech-companies-increase-rnd-spend-but-highlight-clinical-trials-complexity 2025-12-15T13:29:53+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-issues-financial-guidance-full-year-2024 2025-12-15T13:29:24+00:00 0.5 https://www.iconplc.com/news-events/press-releases/new-icon-survey-highlights-importance-combination-therapies-future 2025-12-15T13:28:50+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-reports-fourth-quarter-and-full-year-2023-results 2026-02-05T13:51:02+00:00 0.5 https://www.iconplc.com/news-events/press-releases/first-quarter-2024-earnings-conference-call 2025-12-10T15:20:08+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-announces-cfo-transition 2025-04-23T12:20:50+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-reports-first-quarter-2024-results 2025-04-22T17:21:09+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-announces-pricing-usd-2-billion-notes 2025-12-10T15:19:09+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-releases-its-icon-cares-2023-report 2024-05-09T11:30:36+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-plc-hold-investor-day-meeting-may-30-2024 2025-04-22T17:04:20+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-hosts-investor-day-and-updates-full-year-2024-financial-guidance 2025-04-22T16:23:20+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-recognised-leadership-position-clinical-research-industry-and 2025-04-22T15:37:19+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-announces-results-annual-general-meeting-and-changes-board 2025-04-23T14:16:40+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-reports-second-quarter-2024-results 2025-04-22T16:16:37+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-announces-appointment-new-chief-financial-officer-cfo 2025-04-22T16:13:58+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-survey-highlights-scale-focus-precision-therapies-increasingly 2025-04-22T15:35:42+01:00 0.5 https://www.iconplc.com/news-events/press-releases/ICON-reports-third-quarter-2024-results 2025-04-22T15:57:08+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-survey-highlights-sustained-investment-ai-and-digital-rd-innovation 2025-04-23T12:20:04+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-announces-appointment-chief-operating-officer 2025-04-22T15:55:53+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-and-its-employees-celebrated-excellence-field-clinical-research 2025-04-22T15:33:50+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-plc-present-43rd-annual-jp-morgan-healthcare-conference 2025-04-23T12:07:44+01:00 0.5 https://www.iconplc.com/news-events/press-releases/biomarker-and-trial-optimisation-needed-drive-rd-progress-alzheimers-and 2025-04-22T15:36:08+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-issues-financial-guidance-full-year-2025 2025-04-22T15:54:07+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-portfolio-ai-tools-drives-clinical-trial-efficiencies 2025-04-23T13:57:32+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-reports-fourth-quarter-and-full-year-2024-results 2025-04-22T13:03:45+01:00 0.5 https://www.iconplc.com/news-events/press-releases/mural-health-and-icon-announce-partnership 2026-02-25T11:37:17+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-report-first-quarter-2025-results 2025-10-23T11:30:31+01:00 0.5 https://www.iconplc.com/news-events/press-releases/global-icon-survey-shows-need-more-efficient-obesity-clinical-trial 2026-02-25T11:40:09+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-releases-its-icon-cares-2024-report 2025-10-23T11:51:58+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-plc-schedules-second-quarter-2025-earnings-conference-call 2025-06-23T11:32:11+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-and-its-employees-recognised-clinical-research-industry-leaders-and 2025-10-23T11:53:31+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icons-leadership-and-performance-phase-1-clinical-trials-recognised 2025-07-16T12:16:45+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-reports-second-quarter-2025-results 2025-07-23T21:15:47+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-announces-results-annual-general-meeting 2025-07-23T21:24:42+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-plc-provides-update-vaccine-study 2025-10-23T11:43:05+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-plc-participate-upcoming-investor-conferences 2025-09-02T11:01:10+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-announces-ceo-transition 2025-09-04T14:34:55+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-plc-schedules-third-quarter-2025-earnings-conference-call 2025-10-23T11:29:12+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-reports-third-quarter-2025-results 2025-10-23T11:28:51+01:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-plc-present-jefferies-london-healthcare-conference 2025-11-12T13:24:52+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-survey-reveals-increasing-clinical-trial-startup-delays 2025-12-02T12:15:58+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-2025-global-biotech-survey 2025-12-09T12:41:53+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icons-accellacare-site-network-expands-oncology-research-capabilities 2026-01-27T12:15:13+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-plc-provides-update-timing-fourth-quarter-and-full-year-2025 2026-03-24T15:47:22+00:00 0.5 https://www.iconplc.com/news-events/press-releases/icon-and-advarra-introduce-new-research-ready-connected-site-network 2026-03-24T12:35:49+00:00 0.5 https://www.iconplc.com/about/company-history 2026-03-31T13:54:44+01:00 0.5 https://www.iconplc.com/about-icon/environmental-social-and-governance/environment 2025-05-22T11:50:26+01:00 0.5 https://www.iconplc.com/about-icon/environmental-social-and-governance/governance 2026-02-25T11:48:29+00:00 0.5 https://www.iconplc.com/about/environmental-social-and-governance 2026-02-25T18:45:43+00:00 0.5 https://www.iconplc.com/about-icon/environmental-social-and-governance/social 2025-12-09T11:26:58+00:00 0.5 https://www.iconplc.com/about/icon-in-asia-pacific 2026-04-02T14:17:20+01:00 0.5 https://www.iconplc.com/about-icon/icon-asia-pacific/japan 2026-02-10T10:53:39+00:00 0.5 https://www.iconplc.com/about/icon-in-latin-america 2024-12-03T09:36:17+00:00 0.5 https://www.iconplc.com/about 2025-12-12T09:41:53+00:00 0.5 https://www.iconplc.com/about/leadership/board-of-directors 2026-02-10T09:13:33+00:00 0.5 https://www.iconplc.com/about/leadership 2026-03-31T14:20:14+01:00 0.5 https://www.iconplc.com/about/quality 2026-02-10T08:53:03+00:00 0.5 https://www.iconplc.com/careers/gender-pay-gap-reports 2026-03-30T14:54:16+01:00 0.5 https://www.iconplc.com/careers 2026-02-04T09:01:35+00:00 0.5 https://www.iconplc.com/contact/enquiry-form 2025-12-09T08:14:29+00:00 0.5 https://www.iconplc.com/contact/firecrest-customer-support 2025-12-09T08:13:55+00:00 0.5 https://www.iconplc.com/contact/global-office-locator 2026-03-30T09:21:51+01:00 0.5 https://www.iconplc.com/contact 2025-12-02T14:15:47+00:00 0.5 https://www.iconplc.com/contact/investigators 2025-12-09T08:11:24+00:00 0.5 https://www.iconplc.com/contact/media 2025-12-09T08:10:50+00:00 0.5 https://www.iconplc.com/contact/submit-rfp 2025-12-09T09:59:41+00:00 0.5 https://www.iconplc.com/contact/thank-you 2025-12-02T14:25:53+00:00 0.5 https://www.iconplc.com/disclaimer 2025-12-02T14:28:35+00:00 0.5 https://www.iconplc.com/french-gender-equality-index 2026-02-25T12:37:06+00:00 0.5 https://www.iconplc.com/icon-development-solutions-limited-pension-and-life-assurance 2026-03-13T12:20:26+00:00 0.5 https://www.iconplc.com/home 2026-03-27T07:25:00+00:00 0.5 https://www.iconplc.com/insights/digital-disruption/ai-and-clinical-trials/impact-of-ai-on-outcomes-based-contracting 2024-05-07T12:23:22+01:00 0.5 https://www.iconplc.com/insights/digital-disruption/ai-insights 2026-02-25T12:40:16+00:00 0.5 https://www.iconplc.com/insights/digital-disruption/ai-and-clinical-trials/using-ai-for-site-id-and-selection 2025-04-11T13:41:42+01:00 0.5 https://www.iconplc.com/insights/digital-disruption/anonymisation-of-sdtm-for-data-sharing 2025-12-08T14:14:40+00:00 0.5 https://www.iconplc.com/insights/digital-disruption/clinical-trial-tokenisation 2026-02-25T13:35:58+00:00 0.5 https://www.iconplc.com/insights/digital-disruption/mHealth-wearables/closing-the-evidence-gap 2025-08-12T11:41:37+01:00 0.5 https://www.iconplc.com/insights/digital-disruption 2026-03-10T14:49:47+00:00 0.5 https://www.iconplc.com/insights/digital-disruption/remote-patient-monitoring/cybersecurity 2026-03-09T16:13:25+00:00 0.5 https://www.iconplc.com/insights/digital-disruption/mHealth-wearables/digital-endpoints 2026-03-24T08:38:26+00:00 0.5 https://www.iconplc.com/insights/digital-disruption/mHealth-wearables 2026-02-18T18:03:38+00:00 0.5 https://www.iconplc.com/insights/digital-disruption/mHealth-wearables/personalising-digital-health 2025-08-12T11:23:16+01:00 0.5 https://www.iconplc.com/insights/digital-disruption/real-world-data 2026-02-25T14:06:32+00:00 0.5 https://www.iconplc.com/insights/digital-disruption/real-world-data/maximise-rwe-value 2024-05-07T12:35:13+01:00 0.5 https://www.iconplc.com/insights/digital-disruption/real-world-data/meeting-evidentiary-needs 2024-05-07T12:30:28+01:00 0.5 https://www.iconplc.com/insights/digital-disruption/real-world-data/post-market-surveillance 2026-02-25T14:14:34+00:00 0.5 https://www.iconplc.com/insights 2025-09-29T11:15:36+01:00 0.5 https://www.iconplc.com/insights/patient-centricity/agile-clinical-monitoring 2025-12-09T10:10:18+00:00 0.5 https://www.iconplc.com/insights/patient-centricity/capturing-the-voice-of-the-patient-in-clinical-trials 2024-05-07T11:17:38+01:00 0.5 https://www.iconplc.com/insights/patient-centricity/charting-the-managed-access-program 2024-05-07T12:26:31+01:00 0.5 https://www.iconplc.com/insights/patient-centricity/diversity-and-inclusion-in-clinical-trials/diversity-and-inclusion-in-clinical-trials-whitepaper 2024-05-07T10:36:16+01:00 0.5 https://www.iconplc.com/insights/patient-centricity/inclusion-clinical-trials 2026-02-25T14:22:54+00:00 0.5 https://www.iconplc.com/insights/patient-centricity/exploring-the-patient-perspective-from-different-angles 2024-05-07T11:34:44+01:00 0.5 https://www.iconplc.com/insights/patient-centricity 2026-03-10T14:57:42+00:00 0.5 https://www.iconplc.com/insights/patient-centricity/patient-safety-and-pharmacovigilance/a-guide-to-safety-data-migrations 2024-05-01T11:38:08+01:00 0.5 https://www.iconplc.com/insights/patient-centricity/patient-safety-and-pharmacovigilance 2026-02-25T14:58:55+00:00 0.5 https://www.iconplc.com/insights/patient-centricity/patient-safety-and-pharmacovigilance/taking-safety-reporting-next-level 2026-02-25T15:07:40+00:00 0.5 https://www.iconplc.com/insights/patient-centricity/patient-safety-and-pharmacovigilance/outsourced-pharmacovigilance 2024-05-07T11:58:39+01:00 0.5 https://www.iconplc.com/insights/patient-centricity/patient-safety-and-pharmacovigilance/evolution-pharmacovigilance-system 2024-05-07T10:28:03+01:00 0.5 https://www.iconplc.com/insights/patient-centricity/patient-safety-and-pharmacovigilance/sponsor-and-cro-pharmacovigilance-and-safety-alliances 2026-02-25T15:16:02+00:00 0.5 https://www.iconplc.com/insights/patient-centricity/patient-safety-and-pharmacovigilance/understanding-the-periodic-benefit-risk-evaluation-report 2024-05-07T10:38:42+01:00 0.5 https://www.iconplc.com/insights/patient-centricity/patient-voice-survey-decentralised-and-hybrid-trials 2026-02-26T10:17:23+00:00 0.5 https://www.iconplc.com/insights/patient-centricity/patient-voice-survey 2025-11-06T09:35:49+00:00 0.5 https://www.iconplc.com/insights/patient-centricity/reimagining-patient-centricity-with-the-iomt 2024-05-07T12:07:16+01:00 0.5 https://www.iconplc.com/insights/patient-centricity/using-longitudinal-qualitative-research-to-capture-the-patient-voice 2024-10-09T07:29:57+01:00 0.5 https://www.iconplc.com/insights/regulatory-intelligence/accelerate-regulatory-document-writing 2024-04-23T15:03:08+01:00 0.5 https://www.iconplc.com/insights/regulatory/an-innovative-approach-to-rare-disease-clinical-development 2026-02-26T10:23:44+00:00 0.5 https://www.iconplc.com/insights/regulatory-intelligence/current-overview-data-sharing-within-clinical-trial-transparency 2024-04-23T15:06:25+01:00 0.5 https://www.iconplc.com/insights/regulatory/eu-ctr/ema-guideline-on-computerised-systems-and-electronic-data 2024-04-22T16:40:20+01:00 0.5 https://www.iconplc.com/insights/regulatory/eu-ctr/eu-clinical-trials-regulation 2024-04-22T16:44:34+01:00 0.5 https://www.iconplc.com/insights/regulatory-intelligence/eu-clinical-trials-regulation 2026-02-26T10:28:19+00:00 0.5 https://www.iconplc.com/insights/regulatory-intelligence/eu-regulations/eu-mdr-and-ivdr-transition-extension-what-changes 2024-05-27T07:53:19+01:00 0.5 https://www.iconplc.com/insights/regulatory-intelligence/eu-regulations 2026-02-26T10:36:50+00:00 0.5 https://www.iconplc.com/insights/regulatory-intelligence/eu-regulations/ivdr-technical-file-remediation 2024-05-27T07:53:44+01:00 0.5 https://www.iconplc.com/insights/regulatory/eu-regulations/mdr-ivdr-brings-higher-costs-and-bottlenecks 2025-06-24T14:21:57+01:00 0.5 https://www.iconplc.com/insights/regulatory-intelligence/eu-regulations/seeking-parallel-consultation-regulators-and-hta 2024-05-27T07:55:04+01:00 0.5 https://www.iconplc.com/insights/regulatory-intelligence/eu-regulations/ivdr-journey 2024-05-27T07:55:20+01:00 0.5 https://www.iconplc.com/insights/regulatory/global-agency-meetings 2024-04-22T16:59:50+01:00 0.5 https://www.iconplc.com/insights/regulatory-intelligence 2026-03-13T11:14:42+00:00 0.5 https://www.iconplc.com/insights/regulatory-intelligence/keeping-end-mind-key-considerations-creating-plain-language 2024-04-23T22:58:39+01:00 0.5 https://www.iconplc.com/insights/regulatory-intelligence/navigating-orphan-drug-development-early-phase-marketing 2024-04-23T23:01:20+01:00 0.5 https://www.iconplc.com/insights/regulatory-intelligence/procedural-and-regulatory-know-how-china-biotechs-eu 2026-02-26T10:45:36+00:00 0.5 https://www.iconplc.com/insights/regulatory/race-act 2026-02-26T10:51:41+00:00 0.5 https://www.iconplc.com/insights/regulatory/race-for-children-act1 2024-04-22T17:11:21+01:00 0.5 https://www.iconplc.com/insights/regulatory/regulatory-considerations-for-biotech 2026-02-26T10:56:38+00:00 0.5 https://www.iconplc.com/insights/regulatory-intelligence/regulatory-intelligence-newsletter 2026-03-25T16:08:20+00:00 0.5 https://www.iconplc.com/insights/regulatory-intelligence/requirements-strategy-considerations-within-clinical-trial 2025-09-15T12:40:31+01:00 0.5 https://www.iconplc.com/insights/regulatory/spotlight-on-regulatory-reforms-in-china 2024-04-23T14:55:47+01:00 0.5 https://www.iconplc.com/insights/regulatory-intelligence/transfer-marketing-authorisation 2025-09-15T12:43:32+01:00 0.5 https://www.iconplc.com/insights/therapeutics/cardiovascular 2026-02-26T11:01:24+00:00 0.5 https://www.iconplc.com/insights/therapeutics/cardiovascular/mitigating-the-impact-of-covid19-on-cardiovascular-trials 2024-04-23T23:19:12+01:00 0.5 https://www.iconplc.com/insights/therapeutics/cell-and-gene-therapies/approaching-the-car-t-cell-therapy-horizon 2024-04-23T23:23:47+01:00 0.5 https://www.iconplc.com/insights/therapeutics/cell-and-gene-therapies/cell-and-gene-therapy-clinical-trials 2024-04-23T23:25:45+01:00 0.5 https://www.iconplc.com/insights/therapeutics/cell-and-gene-therapies 2026-02-26T11:08:57+00:00 0.5 https://www.iconplc.com/insights/therapeutics/cell-and-gene-therapies/long-term-follow-up-studies-of-cell-and-gene-therapies 2024-04-23T23:27:54+01:00 0.5 https://www.iconplc.com/insights/therapeutics/cell-and-gene-therapies/mainstreaming-cell-gene-therapies 2024-04-23T23:31:57+01:00 0.5 https://www.iconplc.com/insights/therapeutics/central-nervous-system/a-mind-for-digital-therapeutics 2026-03-23T15:07:08+00:00 0.5 https://www.iconplc.com/insights/therapeutics/central-nervous-system/challenges-and-opportunities-in-traumatic-brain-injury-clinical-trials 2024-04-23T23:40:23+01:00 0.5 https://www.iconplc.com/insights/therapeutics/central-nervous-system 2026-04-02T16:38:19+01:00 0.5 https://www.iconplc.com/insights/therapeutics/central-nervous-system/key-considerations-for-parkinsons-disease-trials 2026-03-04T11:26:04+00:00 0.5 https://www.iconplc.com/insights/therapeutics/central-nervous-system/key-considerations-in-chronic-pain-clinical-trials 2024-04-24T09:10:43+01:00 0.5 https://www.iconplc.com/insights/therapeutics/glycomics 2024-04-24T09:36:42+01:00 0.5 https://www.iconplc.com/insights/therapeutics 2026-03-11T08:49:52+00:00 0.5 https://www.iconplc.com/insights/therapeutics/infectious-diseases/antimicrobial-resistance 2025-12-08T13:57:50+00:00 0.5 https://www.iconplc.com/therapeutics/therapeutics-insights/infectious-diseases/considerations-strengthening-vaccine 2024-05-23T14:43:01+01:00 0.5 https://www.iconplc.com/insights/therapeutics/infectious-diseases/covid-19-vaccine-trials 2025-09-09T13:17:52+01:00 0.5 https://www.iconplc.com/insights/therapeutics/infectious-diseases/covid-19-vaccines-pass 2025-09-09T12:02:34+01:00 0.5 https://www.iconplc.com/insights/therapeutics/infectious-diseases/hiv 2026-01-22T06:19:45+00:00 0.5 https://www.iconplc.com/insights/therapeutics/infectious-diseases 2026-04-02T13:17:26+01:00 0.5 https://www.iconplc.com/insights/therapeutics/infectious-diseases/the-value-of-dynamic-transmission-models 2024-04-24T09:54:37+01:00 0.5 https://www.iconplc.com/insights/therapeutics/hepatology 2026-02-20T09:18:51+00:00 0.5 https://www.iconplc.com/insights/therapeutics/nash/the-voice-of-nash-investigators-in-patient-recruitment 2024-04-24T10:03:39+01:00 0.5 https://www.iconplc.com/insights/therapeutics/endocrine-and-metabolic-disorders/obesity/addressing-obesitys-impact 2024-04-24T10:00:30+01:00 0.5 https://www.iconplc.com/insights/therapeutics/obesity 2026-02-26T11:42:18+00:00 0.5 https://www.iconplc.com/insights/therapeutics/endocrine-and-metabolic-disorders/obesity/trends-and-challenges-in-obesity-research 2025-04-11T13:55:04+01:00 0.5 https://www.iconplc.com/insights/therapeutics/oncology 2026-04-02T16:30:31+01:00 0.5 https://www.iconplc.com/insights/therapeutics/pediatrics 2026-03-26T09:27:53+00:00 0.5 https://www.iconplc.com/insights/therapeutics/pediatrics/pediatric-risk-assessment-map 2024-10-29T15:53:32+00:00 0.5 https://www.iconplc.com/insights/therapeutics/rare-and-orphan-diseases/advanced-therapies-for-rare-diseases 2024-04-24T12:01:39+01:00 0.5 https://www.iconplc.com/insights/therapeutics/rare-and-orphan-diseases/cross-border-enrollment-of-rare-disease-patients 2024-04-24T12:18:49+01:00 0.5 https://www.iconplc.com/insights/therapeutics/rare-and-orphan-diseases/crossing-the-finish-line 2024-04-24T12:12:37+01:00 0.5 https://www.iconplc.com/insights/therapeutics/rare-and-orphan-diseases/diversity-equity-and-inclusion-in-rare-disease-trials 2024-04-24T12:10:20+01:00 0.5 https://www.iconplc.com/insights/therapeutics/rare-and-orphan-diseases/identify-and-mitigate-risks-to-rare-disease-clinical-programmes 2024-04-24T12:27:46+01:00 0.5 https://www.iconplc.com/insights/therapeutics/rare-and-orphan-diseases 2026-03-09T16:07:45+00:00 0.5 https://www.iconplc.com/insights/therapeutics/rare-and-orphan-diseases/leveraging-historical-data-for-use-in-rare-disease-trials 2024-04-24T12:35:24+01:00 0.5 https://www.iconplc.com/insights/therapeutics/rare-and-orphan-diseases/natural-history-studies-to-improve-drug-development-in-rare-diseases 2024-04-24T12:23:28+01:00 0.5 https://www.iconplc.com/insights/therapeutics/rare-and-orphan-diseases/patient-centricity-in-orphan-drug-development 2024-04-24T12:29:55+01:00 0.5 https://www.iconplc.com/insights/therapeutics/rare-and-orphan-diseases/the-key-to-remarkable-rare-disease-registries 2024-04-24T12:21:17+01:00 0.5 https://www.iconplc.com/insights/transforming-trials/adaptive-clinical-trials/faster-path-to-market 2024-05-08T13:30:28+01:00 0.5 https://www.iconplc.com/insights/transforming-trials/adaptive-clinical-trials 2026-04-02T18:08:15+01:00 0.5 https://www.iconplc.com/insights/transforming-trials/best-practices-to-increase-engagement-with-medical-and-scientific-poster-content 2024-04-15T10:12:08+01:00 0.5 https://www.iconplc.com/insights/transforming-trials/decentralised-and-hybrid-clinical-trials/biopharma-perspective-panel-discussion 2025-08-06T09:27:10+01:00 0.5 https://www.iconplc.com/insights/transforming-trials/decentralised-and-hybrid-clinical-trials/decentralised-trials-plan 2026-02-10T15:11:49+00:00 0.5 https://www.iconplc.com/insights/transforming-trials/decentralised-and-hybrid-clinical-trials 2026-02-25T14:18:27+00:00 0.5 https://www.iconplc.com/insights/transforming-trials/decentralised-and-hybrid-clinical-trials/practical-considerations-in-transitioning-to-dct 2024-04-15T14:50:16+01:00 0.5 https://www.iconplc.com/insights/transforming-trials/decentralised-and-hybrid-clinical-trials/regulatory-labyrinth-of-technology 2024-04-15T14:55:29+01:00 0.5 https://www.iconplc.com/insights/transforming-trials/ecoa-implementation 2026-02-26T12:24:33+00:00 0.5 https://www.iconplc.com/insights/transforming-trials/functional-model-insights/clinical-trials-in-japan-an-enterprise-growth-and-management-strategy 2024-04-15T15:09:18+01:00 0.5 https://www.iconplc.com/insights/transforming-trials/blended-solutions-insights 2026-02-26T12:30:46+00:00 0.5 https://www.iconplc.com/insights/transforming-trials/functional-model-insights/investments-in-supply-of-cras 2024-04-15T15:10:36+01:00 0.5 https://www.iconplc.com/insights/transforming-trials/functional-model-insights/the-evolution-of-fsp-not-just-for-large-pharma 2024-04-15T15:11:41+01:00 0.5 https://www.iconplc.com/insights/transforming-trials/implications-of-covid-19-on-statistical-design 2024-10-14T12:01:33+01:00 0.5 https://www.iconplc.com/insights/transforming-trials/improving-pharma-research-and-development-efficiency 2024-04-15T15:17:29+01:00 0.5 https://www.iconplc.com/insights/transforming-trials/increasing-complexity-and-declining-roi-in-drug-development 2024-04-16T09:19:04+01:00 0.5 https://www.iconplc.com/insights/transforming-trials 2026-02-25T15:02:47+00:00 0.5 https://www.iconplc.com/insights/transforming-trials/partnership-insights/exploring-partnership-culture 2024-04-16T09:52:12+01:00 0.5 https://www.iconplc.com/insights/transforming-trials/partnership-insights 2026-02-26T12:37:44+00:00 0.5 https://www.iconplc.com/insights/transforming-trials/risk-based-quality-management 2024-04-16T09:56:40+01:00 0.5 https://www.iconplc.com/insights/transforming-trials/transforming-the-rd-model 2024-04-16T09:59:00+01:00 0.5 https://www.iconplc.com/insights/value-based-healthcare/accelerated-early-clinical-manufacturing 2025-02-21T12:58:25+00:00 0.5 https://www.iconplc.com/insights/value-based-healthcare/cardiovascular-medical-devices 2026-03-13T10:11:43+00:00 0.5 https://www.iconplc.com/insights/value-based-healthcare/cms-price-negotiation-for-part-d-drugs 2026-02-27T12:15:42+00:00 0.5 https://www.iconplc.com/insights/value-based-healthcare/covid-19-navigating-global-market-access 2024-04-16T11:55:53+01:00 0.5 https://www.iconplc.com/insights/value-based-healthcare/ensuring-scientific-rigor-in-external-control-arms 2026-04-02T18:09:21+01:00 0.5 https://www.iconplc.com/insights/value-based-healthcare/evidence-synthesis 2024-04-16T12:50:01+01:00 0.5 https://www.iconplc.com/insights/value-based-healthcare/health-technology-assessm 2025-08-22T08:30:01+01:00 0.5 https://www.iconplc.com/insights/value-based-healthcare/icer 2026-02-06T08:42:27+00:00 0.5 https://www.iconplc.com/insights/value-based-healthcare/icers-impact-on-payer-decision-making 2024-04-16T13:00:21+01:00 0.5 https://www.iconplc.com/insights/value-based-healthcare 2026-03-02T17:28:35+00:00 0.5 https://www.iconplc.com/insights/value-based-healthcare/making-sense-of-the-biosimilar-market 2024-04-16T13:01:32+01:00 0.5 https://www.iconplc.com/insights/value-based-healthcare/medical-communications-in-early-phase-product-development 2024-04-16T13:03:36+01:00 0.5 https://www.iconplc.com/insights/value-based-healthcare/navigating-challenges-and-opportunities-value-based-healthcare 2024-04-16T13:04:49+01:00 0.5 https://www.iconplc.com/insights/value-based-healthcare/payer-reliance-on-icer-assessments-and-perceptions-on-value-based-pricing 2024-04-16T13:06:31+01:00 0.5 https://www.iconplc.com/insights/value-based-healthcare/payers-perspectives-on-digital-therapeutics 2024-04-16T13:08:01+01:00 0.5 https://www.iconplc.com/insights/value-based-healthcare/precision-medicine 2024-04-16T13:09:02+01:00 0.5 https://www.iconplc.com/insights/value-based-healthcare/rwe-generation-cross-sect 2024-04-16T13:11:17+01:00 0.5 https://www.iconplc.com/insights/value-based-healthcare/survey-results-how-to-engage-healthcare-decision-makers 2024-04-16T13:12:28+01:00 0.5 https://www.iconplc.com/insights/value-based-healthcare/the-affordability-hurdle-for-gene-therapies 2024-04-16T13:14:38+01:00 0.5 https://www.iconplc.com/insights/value-based-healthcare/the-role-of-icer-as-an-independent-hta-organisation 2024-04-16T13:15:55+01:00 0.5 https://www.iconplc.com/insights/value-based-healthcare/US-payers-and-PROs 2024-04-16T13:19:16+01:00 0.5 https://www.iconplc.com/insights/videos 2024-06-11T10:54:44+01:00 0.5 https://www.iconplc.com/investigators/clinical-study-investigators 2026-02-27T12:21:28+00:00 0.5 https://www.iconplc.com/investigators/early-phase 2024-05-10T10:17:57+01:00 0.5 https://www.iconplc.com/investigators 2025-12-23T12:41:30+00:00 0.5 https://www.iconplc.com/investigators/investigator-site-resource-centre/commercial-invoices-uk-clinical-trial-sites 2024-05-10T10:43:14+01:00 0.5 https://www.iconplc.com/investigators/investigator-site-resource-centre/faqs 2025-12-09T11:13:18+00:00 0.5 https://www.iconplc.com/investigators/investigator-site-resource-centre/holiday-schedule 2026-02-27T12:34:56+00:00 0.5 https://www.iconplc.com/investigators/investigator-site-resource-centre 2026-02-27T12:46:46+00:00 0.5 https://www.iconplc.com/investigators/investigator-site-resource-centre/isite 2024-05-10T10:59:09+01:00 0.5 https://www.iconplc.com/investigators/investigator-site-resource-centre/lab-certificates 2026-04-01T08:35:25+01:00 0.5 https://www.iconplc.com/investigators/investigator-site-resource-centre/packaging-instructions 2024-05-10T11:07:47+01:00 0.5 https://www.iconplc.com/investigators/investigator-site-resource-centre/site-training 2024-07-25T11:13:23+01:00 0.5 https://www.iconplc.com/investigators/investigator-site-resource-centre/track-shipment 2024-11-21T13:46:36+00:00 0.5 https://www.iconplc.com/investigators/register/early-phase 2024-05-10T11:22:27+01:00 0.5 https://www.iconplc.com/investigators/register 2025-12-09T11:20:49+00:00 0.5 https://www.iconplc.com/investigators/transparency-loi-bertrand/contact 2024-05-10T12:00:29+01:00 0.5 https://www.iconplc.com/investigators/transparency-loi-bertrand 2024-05-10T12:04:46+01:00 0.5 https://www.iconplc.com/investigators/transparency-loi-bertrand/la-reglementation 2025-12-09T08:51:57+00:00 0.5 https://www.iconplc.com/investigators/transparency-loi-bertrand/les-donnees-de-transparence 2025-04-22T13:58:22+01:00 0.5 https://www.iconplc.com/news-events/icon-to-acquire-pra-health-sciences/joint-letter-from-ceos 2026-02-06T08:42:45+00:00 0.5 https://www.iconplc.com/news-events 2026-02-26T15:35:32+00:00 0.5 https://www.iconplc.com/news-events/mediakit/facts-and-figures 2025-12-10T15:36:25+00:00 0.5 https://www.iconplc.com/news-events/mediakit/icon-spokespeople 2026-01-13T17:17:25+00:00 0.5 https://www.iconplc.com/news-events/mediakit 2026-02-03T13:27:59+00:00 0.5 https://www.iconplc.com/news-events/press-releases 2026-01-06T14:37:12+00:00 0.5 https://www.iconplc.com/news-events/social-media 2026-02-25T10:18:09+00:00 0.5 https://www.iconplc.com/preferences 2025-12-18T08:05:13+00:00 0.5 https://www.iconplc.com/privacy/business-professionals 2025-12-18T08:07:57+00:00 0.5 https://www.iconplc.com/privacy/icons-ai-ethical-principles 2026-01-13T10:26:02+00:00 0.5 https://www.iconplc.com/privacy 2025-12-18T08:08:35+00:00 0.5 https://www.iconplc.com/privacy/international-transfers 2025-12-18T08:09:15+00:00 0.5 https://www.iconplc.com/privacy/job-applicants 2025-12-18T08:10:31+00:00 0.5 https://www.iconplc.com/privacy/potential-research-participants-and-general-website-users 2025-12-18T08:11:58+00:00 0.5 https://www.iconplc.com/privacy/site-data-protection 2025-12-18T08:12:57+00:00 0.5 https://www.iconplc.com/privacy/us-swiss-policy 2025-12-18T08:14:14+00:00 0.5 https://www.iconplc.com/about-icon/environmental-social-and-governance/governance/icon-suppliers 2026-02-27T13:10:31+00:00 0.5 https://www.iconplc.com/remote 2026-01-13T09:21:29+00:00 0.5 https://www.iconplc.com/therapeutics/biosimilars 2026-03-11T13:51:40+00:00 0.5 https://www.iconplc.com/sectors/biotech/emerging-biotech-funding 2026-03-26T15:48:19+00:00 0.5 https://www.iconplc.com/sectors/biotech/externalised-development 2026-02-11T11:51:12+00:00 0.5 https://www.iconplc.com/sectors/biotech 2026-03-20T09:04:45+00:00 0.5 https://www.iconplc.com/sectors/government-and-public-health 2026-03-13T16:40:47+00:00 0.5 https://www.iconplc.com/sectors/government-and-public-health/our-africa-experience 2026-03-16T10:16:16+00:00 0.5 https://www.iconplc.com/sectors/government-and-public-health/our-customers 2026-02-16T07:36:20+00:00 0.5 https://www.iconplc.com/sectors/government-and-public-health/our-services 2026-02-11T11:53:16+00:00 0.5 https://www.iconplc.com/sectors 2025-09-29T11:15:36+01:00 0.5 https://www.iconplc.com/sectors/medical-device/clinical-operations 2025-12-08T11:15:15+00:00 0.5 https://www.iconplc.com/sectors/medical-device/device-therapeutic-expertise 2026-02-11T12:02:32+00:00 0.5 https://www.iconplc.com/sectors/medical-device 2026-03-02T11:26:50+00:00 0.5 https://www.iconplc.com/sectors/medical-device/qa-support 2026-02-11T12:07:53+00:00 0.5 https://www.iconplc.com/solutions/consulting/regulatory-affairs/medical-devices-ivd 2026-03-11T08:51:58+00:00 0.5 https://www.iconplc.com/sectors/pharma/partnerships 2026-02-11T14:08:04+00:00 0.5 https://www.iconplc.com/sectors/pharma 2026-02-24T11:16:34+00:00 0.5 https://www.iconplc.com/site-cookies 2025-12-18T08:15:01+00:00 0.5 https://www.iconplc.com/solutions/cardiac-safety-solutions 2026-02-12T10:37:13+00:00 0.5 https://www.iconplc.com/solutions/clinical-scientific-operations/biostatistics 2026-03-02T13:57:09+00:00 0.5 https://www.iconplc.com/solutions/clinical-scientific-operations/clinical-operations/clinical-monitoring 2026-02-05T13:15:26+00:00 0.5 https://www.iconplc.com/solutions/clinical-scientific-operations/clinical-operations/clinical-monitoring/risk-based 2026-02-05T13:13:07+00:00 0.5 https://www.iconplc.com/solutions/clinical-scientific-operations/clinical-operations 2026-02-05T13:17:09+00:00 0.5 https://www.iconplc.com/solutions/clinical-scientific-operations/clinical-operations/trial-master-file-services 2025-12-16T11:03:05+00:00 0.5 https://www.iconplc.com/solutions/clinical-scientific-operations/clinical-supplies-management 2025-12-11T13:56:33+00:00 0.5 https://www.iconplc.com/solutions/clinical-scientific-operations/covid-19 2026-02-05T13:11:58+00:00 0.5 https://www.iconplc.com/solutions/clinical-scientific-operations/covid-19/covid-19-treatment-and-vaccine-trials 2026-02-05T13:09:06+00:00 0.5 https://www.iconplc.com/solutions/clinical-scientific-operations/clinical-data-science/cdisc-data-standardisation 2026-02-23T09:27:14+00:00 0.5 https://www.iconplc.com/solutions/clinical-scientific-operations/clinical-data-science 2026-02-20T14:41:49+00:00 0.5 https://www.iconplc.com/solutions/clinical-scientific-operations/endpoint-adjudication-services 2026-02-05T13:04:07+00:00 0.5 https://www.iconplc.com/solutions/clinical-and-scientific-operations/global-logistics/depot-and-distribution-services 2026-03-02T15:12:35+00:00 0.5 https://www.iconplc.com/solutions/clinical-and-scientific-operations/global-logistics/factsheets 2026-03-11T11:46:08+00:00 0.5 https://www.iconplc.com/solutions/clinical-scientific-operations/global-logistics 2025-12-15T13:39:55+00:00 0.5 https://www.iconplc.com/solutions/clinical-scientific-operations 2026-03-02T12:09:41+00:00 0.5 https://www.iconplc.com/solutions/clinical-and-scientific-operations/interactive-technologies/helpdesk-services 2026-03-03T10:56:08+00:00 0.5 https://www.iconplc.com/solutions/clinical-scientific-operations/interactive-response-technology 2026-03-03T11:01:39+00:00 0.5 https://www.iconplc.com/solutions/clinical-scientific-operations/investigator-payments 2025-12-01T14:44:35+00:00 0.5 https://www.iconplc.com/solutions/clinical-scientific-operations/investigator-payments/tax-management-and-contracting 2026-03-03T11:06:32+00:00 0.5 https://www.iconplc.com/solutions/clinical-scientific-operations/investigator-payments/need-flexibility 2026-03-03T11:08:12+00:00 0.5 https://www.iconplc.com/solutions/clinical-scientific-operations/medical-affairs 2026-02-05T13:02:50+00:00 0.5 https://www.iconplc.com/solutions/clinical-and-scientific-operations/medical-call-centre-services 2026-02-05T16:57:06+00:00 0.5 https://www.iconplc.com/solutions/clinical-scientific-operations/medical-writing 2026-04-01T08:47:20+01:00 0.5 https://www.iconplc.com/solutions/clinical-scientific-operations/pharmacovigilance/affiliate-level-solution 2026-03-03T11:35:47+00:00 0.5 https://www.iconplc.com/solutions/clinical-and-scientific-operations/pharmacovigilance/ensuring-patient-safety 2026-02-20T14:39:10+00:00 0.5 https://www.iconplc.com/solutions/clinical-scientific-operations/pharmacovigilance 2026-03-19T12:45:26+00:00 0.5 https://www.iconplc.com/solutions/clinical-and-scientific-operations/project-and-program-management 2025-12-15T15:28:23+00:00 0.5 https://www.iconplc.com/solutions/clinical-scientific-operations/accelerated-study-start-up 2026-02-18T07:36:42+00:00 0.5 https://www.iconplc.com/solutions/consulting/asset-development/adaptive-trials 2026-04-02T18:10:08+01:00 0.5 https://www.iconplc.com/solutions/consulting/asset-development/dose-optimisation-strategy 2026-02-05T13:00:01+00:00 0.5 https://www.iconplc.com/solutions/consulting/asset-development/due-diligence-asset-valuation 2026-02-05T12:59:23+00:00 0.5 https://www.iconplc.com/solutions/consulting/asset-development 2026-03-03T13:22:18+00:00 0.5 https://www.iconplc.com/solutions/consulting/asset-development/non-clinical-development 2025-12-05T14:43:04+00:00 0.5 https://www.iconplc.com/solutions/consulting/asset-development/novel-statistical-methods 2026-03-06T11:01:42+00:00 0.5 https://www.iconplc.com/solutions/consulting/asset-development/target-product-profile 2026-03-09T11:38:22+00:00 0.5 https://www.iconplc.com/solutions/consulting/commercial-positioning-consulting/health-economics 2026-03-23T18:34:54+00:00 0.5 https://www.iconplc.com/solutions/consulting/commercial-positioning-consulting 2026-02-11T14:54:24+00:00 0.5 https://www.iconplc.com/solutions/outcome-measures/COAs 2026-01-23T12:09:48+00:00 0.5 https://www.iconplc.com/solutions/consulting/commercial-positioning-consulting/market-access 2026-03-13T10:36:43+00:00 0.5 https://www.iconplc.com/solutions/consulting/commercial-positioning-consulting/market-research-analytics 2025-12-01T15:07:28+00:00 0.5 https://www.iconplc.com/solutions/consulting/commercial-positioning-consulting/medical-communications/creative-and-digital-services/awards 2025-11-21T09:13:17+00:00 0.5 https://www.iconplc.com/solutions/consulting/commercial-positioning-consulting/medical-communications/creative-and-digital-services 2026-03-04T12:02:43+00:00 0.5 https://www.iconplc.com/solutions/consulting/commercial-positioning-consulting/medical-communications 2025-12-08T14:40:01+00:00 0.5 https://www.iconplc.com/solutions/consulting/commercial-positioning-consulting/medical-communications/publication-management 2026-01-23T07:42:00+00:00 0.5 https://www.iconplc.com/solutions/outcome-measures/eCOA-technology 2026-03-04T14:15:39+00:00 0.5 https://www.iconplc.com/solutions/consulting/commercial-positioning-consulting/patient-reported-outcomes 2026-03-06T12:01:03+00:00 0.5 https://www.iconplc.com/solutions/consulting/commercial-positioning-consulting/symphony-health 2026-03-09T11:34:42+00:00 0.5 https://www.iconplc.com/solutions/consulting 2026-03-10T07:12:11+00:00 0.5 https://www.iconplc.com/solutions/consulting/regulatory-affairs/cmc-services 2026-03-04T11:13:32+00:00 0.5 https://www.iconplc.com/solutions/consulting/regulatory-affairs 2026-03-23T12:36:48+00:00 0.5 https://www.iconplc.com/solutions/consulting/regulatory-affairs/regulatory-affairs-clinical-support 2026-03-24T11:34:00+00:00 0.5 https://www.iconplc.com/solutions/consulting/regulatory-affairs/regulatory-strategy 2026-03-05T10:50:42+00:00 0.5 https://www.iconplc.com/solutions/decentralised-clinical-trials/In-home-clinical-services 2026-03-05T13:05:07+00:00 0.5 https://www.iconplc.com/solutions/decentralised-clinical-trials 2026-03-04T12:23:58+00:00 0.5 https://www.iconplc.com/solutions/early-clinical/bioanalytical-laboratories 2026-03-24T11:12:52+00:00 0.5 https://www.iconplc.com/solutions/early-clinical/clinical-research-units 2026-03-23T07:14:39+00:00 0.5 https://www.iconplc.com/solutions/early-clinical/accelerated-pharmaceutical-solutions 2026-03-03T12:30:13+00:00 0.5 https://www.iconplc.com/solutions/early-clinical/data-analysis 2026-03-03T15:21:22+00:00 0.5 https://www.iconplc.com/solutions/early-clinical/early-phase-oncology 2025-11-20T10:43:01+00:00 0.5 https://www.iconplc.com/solutions/early-clinical/clinical-pharmacology 2026-02-23T10:31:13+00:00 0.5 https://www.iconplc.com/solutions/early-clinical 2026-03-02T17:16:27+00:00 0.5 https://www.iconplc.com/solutions/early-clinical/patient-studies 2026-03-04T14:08:45+00:00 0.5 https://www.iconplc.com/solutions/early-clinical/TQT-studies 2026-03-11T08:48:46+00:00 0.5 https://www.iconplc.com/solutions/early-clinical/quantitative-pharmacology-and-pharmacometrics 2026-03-06T14:29:34+00:00 0.5 https://www.iconplc.com/solutions/early-clinical/quality-control-assurance 2025-08-14T09:29:37+01:00 0.5 https://www.iconplc.com/solutions/early-clinical/volunteer-recruitment 2026-03-09T12:28:19+00:00 0.5 https://www.iconplc.com/solutions/medical-imaging/collect-and-hold 2025-04-28T10:06:56+01:00 0.5 https://www.iconplc.com/solutions/medical-imaging/imaging-therapeutic-expertise/cardiovascular 2026-03-03T15:45:25+00:00 0.5 https://www.iconplc.com/solutions/medical-imaging/imaging-therapeutic-expertise/central-nervous-system 2025-12-16T11:21:18+00:00 0.5 https://www.iconplc.com/solutions/medical-imaging/imaging-therapeutic-expertise 2026-02-10T09:53:07+00:00 0.5 https://www.iconplc.com/solutions/medical-imaging/imaging-therapeutic-expertise/metabolic-disease/mashmasld 2025-12-16T11:42:45+00:00 0.5 https://www.iconplc.com/solutions/medical-imaging/imaging-therapeutic-expertise/oncology 2026-03-06T11:06:07+00:00 0.5 https://www.iconplc.com/solutions/medical-imaging 2026-03-02T16:35:44+00:00 0.5 https://www.iconplc.com/solutions/medical-imaging/rescue-studies 2025-04-28T10:09:52+01:00 0.5 https://www.iconplc.com/solutions/medical-imaging/technology-platforms 2025-04-28T10:10:17+01:00 0.5 https://www.iconplc.com/solutions 2025-09-29T11:15:36+01:00 0.5 https://www.iconplc.com/solutions/laboratories/bioanalytical-laboratories/biomarkers 2026-03-03T15:10:28+00:00 0.5 https://www.iconplc.com/solutions/laboratories/bioanalytical-laboratories/flow-cytometry 2026-04-01T13:08:34+01:00 0.5 https://www.iconplc.com/solutions/laboratories/bioanalytical-laboratories 2026-03-12T09:52:23+00:00 0.5 https://www.iconplc.com/solutions/laboratories/bioanalytical-laboratories/lc-msms 2026-02-23T11:01:23+00:00 0.5 https://www.iconplc.com/solutions/laboratories/bioanalytical-laboratories/ligand-binding-assays 2025-12-05T11:36:34+00:00 0.5 https://www.iconplc.com/solutions/laboratories/bioanalytical-laboratories/qpcr 2026-03-03T11:43:49+00:00 0.5 https://www.iconplc.com/solutions/laboratories/biospecimen-services 2025-04-28T10:15:42+01:00 0.5 https://www.iconplc.com/solutions/laboratories/ebook-quantitative-bioanalysis-by-LC-MS-for-the-development-of-biological-drugs 2024-05-22T08:54:43+01:00 0.5 https://www.iconplc.com/solutions/laboratories/global-central-laboratories/digital-pathology 2026-03-04T13:36:03+00:00 0.5 https://www.iconplc.com/solutions/laboratories/global-central-laboratories/global-data-services 2026-03-05T10:43:00+00:00 0.5 https://www.iconplc.com/solutions/laboratories/global-central-laboratories/logistical-tools 2025-09-02T14:01:26+01:00 0.5 https://www.iconplc.com/solutions/laboratories/global-central-laboratories 2026-03-04T10:31:24+00:00 0.5 https://www.iconplc.com/solutions/laboratories/global-central-laboratories/integrated-clinical-research-laboratory-services 2026-01-30T17:22:16+00:00 0.5 https://www.iconplc.com/solutions/laboratories/global-central-laboratories/iris-focus-local-laboratory-results 2026-03-20T11:20:55+00:00 0.5 https://www.iconplc.com/solutions/laboratories/global-central-laboratories/laboratory-facilities 2025-04-28T10:18:27+01:00 0.5 https://www.iconplc.com/solutions/laboratories/global-central-laboratories/quality-assurance 2026-03-06T14:26:40+00:00 0.5 https://www.iconplc.com/solutions/laboratories/global-central-laboratories/testing-capabilities 2025-09-02T14:49:22+01:00 0.5 https://www.iconplc.com/solutions/laboratories 2026-03-05T14:47:53+00:00 0.5 https://www.iconplc.com/solutions/laboratories/specialty-laboratories/clinical-trial-management 2026-02-05T08:39:00+00:00 0.5 https://www.iconplc.com/node/33961 2024-06-12T08:40:20+01:00 0.5 https://www.iconplc.com/solutions/laboratories/specialty-laboratories/flow-cytometry/harness-power-flow-cytometry-drive 2024-06-12T09:29:26+01:00 0.5 https://www.iconplc.com/solutions/laboratories/specialty-laboratories/flow-cytometry 2025-12-05T11:31:15+00:00 0.5 https://www.iconplc.com/solutions/laboratories/specialty-laboratories/histopathology 2024-06-12T08:41:57+01:00 0.5 https://www.iconplc.com/solutions/laboratories/specialty-laboratories 2026-03-09T11:18:59+00:00 0.5 https://www.iconplc.com/solutions/laboratories/specialty-laboratories/platforms-applications-methods 2026-01-23T10:00:51+00:00 0.5 https://www.iconplc.com/solutions/language-services/clinical-and-medical-translations 2026-03-04T10:37:07+00:00 0.5 https://www.iconplc.com/solutions/language-services 2026-02-11T13:57:41+00:00 0.5 https://www.iconplc.com/solutions/language-services/linguistic-validation 2026-03-05T15:11:02+00:00 0.5 https://www.iconplc.com/solutions/language-services/translation-technologies 2026-02-23T11:23:11+00:00 0.5 https://www.iconplc.com/solutions/real-world-intelligence/clinical-trial-tokenisation 2026-03-18T16:27:13+00:00 0.5 https://www.iconplc.com/solutions/real-world-intelligence 2026-02-13T13:37:33+00:00 0.5 https://www.iconplc.com/solutions/site-and-patient-solutions/global-recruitment-solutions/concierge-services 2026-03-04T11:52:28+00:00 0.5 https://www.iconplc.com/solutions/real-world-intelligence/real-world-evidence-and-late-phase-research 2026-02-23T11:49:51+00:00 0.5 https://www.iconplc.com/solutions/real-world-intelligence/real-world-evidence-and-late-phase-research/remote-monitoring 2026-02-05T08:01:33+00:00 0.5 https://www.iconplc.com/solutions/real-world-intelligence/rwe-strategy-and-analytics 2026-03-10T11:13:59+00:00 0.5 https://www.iconplc.com/solutions/site-and-patient-solutions/sites/clinical-site-solutions 2025-12-02T10:44:04+00:00 0.5 https://www.iconplc.com/solutions/site-and-patient-solutions/global-recruitment-solutions 2026-03-26T12:27:26+00:00 0.5 https://www.iconplc.com/solutions/site-and-patient-solutions/global-recruitment-solutions/patient-insights 2026-03-06T11:33:54+00:00 0.5 https://www.iconplc.com/solutions/site-and-patient-solutions/global-recruitment-solutions/patient-recruitment 2026-02-25T14:30:20+00:00 0.5 https://www.iconplc.com/solutions/site-and-patient-solutions 2026-03-09T16:36:18+00:00 0.5 https://www.iconplc.com/solutions/consulting/asset-development/protocol-optimisation 2026-03-06T14:13:12+00:00 0.5 https://www.iconplc.com/solutions/strategic-solutions/careers/cra/china 2026-02-04T12:41:12+00:00 0.5 https://www.iconplc.com/solutions/strategic-solutions/careers 2026-02-05T07:51:51+00:00 0.5 https://www.iconplc.com/solutions/strategic-solutions/data 2026-02-04T12:39:51+00:00 0.5 https://www.iconplc.com/solutions/strategic-solutions 2026-02-05T07:53:49+00:00 0.5 https://www.iconplc.com/solutions/strategic-solutions/operations 2026-02-04T12:38:21+00:00 0.5 https://www.iconplc.com/solutions/strategic-solutions/tech 2026-03-09T11:43:35+00:00 0.5 https://www.iconplc.com/solutions/technologies/ai/cassandra 2025-04-28T10:29:53+01:00 0.5 https://www.iconplc.com/solutions/technologies/control-tower/arcades 2025-04-28T10:30:15+01:00 0.5 https://www.iconplc.com/solutions/technologies/control-tower 2025-10-07T09:02:44+01:00 0.5 https://www.iconplc.com/solutions/technologies/control-tower/oneview 2025-04-28T10:30:59+01:00 0.5 https://www.iconplc.com/solutions/technologies/icon-orca-safety 2026-01-23T12:01:04+00:00 0.5 https://www.iconplc.com/solutions/technologies/evidence-platform 2026-03-04T15:02:27+00:00 0.5 https://www.iconplc.com/solutions/technologies/firecrest/engage/pre-screen 2026-02-04T12:19:21+00:00 0.5 https://www.iconplc.com/solutions/technologies/firecrest/automate 2026-03-04T14:53:32+00:00 0.5 https://www.iconplc.com/solutions/technologies/firecrest/engage/referral-management-console 2025-04-28T10:32:55+01:00 0.5 https://www.iconplc.com/solutions/technologies/firecrest/engage/safety-letters 2026-03-09T10:20:31+00:00 0.5 https://www.iconplc.com/solutions/technologies/firecrest/engage/site-question-management 2026-03-09T10:56:57+00:00 0.5 https://www.iconplc.com/solutions/technologies/firecrest/automate/study-news 2025-04-28T10:34:01+01:00 0.5 https://www.iconplc.com/solutions/technologies/firecrest/engage/document-exchange-and-tracking 2026-02-04T12:19:57+00:00 0.5 https://www.iconplc.com/solutions/technologies/firecrest/educate 2026-02-27T15:12:11+00:00 0.5 https://www.iconplc.com/solutions/technologies/firecrest/learn/training 2026-02-04T12:18:22+00:00 0.5 https://www.iconplc.com/solutions/technologies/firecrest/learn/medical-animation 2026-03-06T10:31:51+00:00 0.5 https://www.iconplc.com/solutions/technologies/firecrest/educate/patient-education 2026-02-04T12:20:32+00:00 0.5 https://www.iconplc.com/solutions/technologies/firecrest/learn/visit-visit-guide 2026-02-04T12:17:50+00:00 0.5 https://www.iconplc.com/solutions/technologies/firecrest 2026-03-04T15:12:19+00:00 0.5 https://www.iconplc.com/solutions/technologies/firecrest/site-portal 2025-12-02T10:57:38+00:00 0.5 https://www.iconplc.com/solutions/technologies/flex-advantage-for-adaptive-trials 2026-04-02T18:10:55+01:00 0.5 https://www.iconplc.com/solutions/technologies/flex-advantage/helpdesk-services 2026-03-02T10:47:54+00:00 0.5 https://www.iconplc.com/solutions/technologies/flex-advantage 2025-11-07T11:51:31+00:00 0.5 https://www.iconplc.com/solutions/technologies/icomaster-for-etmf 2025-04-28T10:38:05+01:00 0.5 https://www.iconplc.com/solutions/technologies/icon-digital-platform 2026-03-05T12:20:28+00:00 0.5 https://www.iconplc.com/solutions/technologies/clinical-data-studio 2025-08-14T16:15:42+01:00 0.5 https://www.iconplc.com/solutions/technologies/medical-imaging-technology 2025-04-28T10:39:12+01:00 0.5 https://www.iconplc.com/solutions/technologies 2026-03-26T14:25:54+00:00 0.5 https://www.iconplc.com/solutions/technologies/nonmem 2026-03-02T11:33:02+00:00 0.5 https://www.iconplc.com/solutions/technologies/nonmem/nonmem-pdx-pop-faqs 2026-03-06T10:57:06+00:00 0.5 https://www.iconplc.com/solutions/technologies/ai/one-search 2026-03-06T11:10:26+00:00 0.5 https://www.iconplc.com/solutions/technologies/patient-engagement-platform 2026-03-02T11:45:01+00:00 0.5 https://www.iconplc.com/solutions/technologies/pdx-pop 2026-03-06T12:23:05+00:00 0.5 https://www.iconplc.com/solutions/technologies/prism-eclinical-solution 2026-03-06T14:00:01+00:00 0.5 https://www.iconplc.com/solutions/technologies/pubshub 2026-03-02T11:58:40+00:00 0.5 https://www.iconplc.com/solutions/technologies/pubshub/journals-congressessm 2026-03-05T14:32:22+00:00 0.5 https://www.iconplc.com/solutions/technologies/pubshub/knowledge-manager 2026-03-05T14:38:02+00:00 0.5 https://www.iconplc.com/solutions/technologies/pubshub/pmsolutionsm 2026-03-06T13:47:53+00:00 0.5 https://www.iconplc.com/solutions/technologies/signet 2024-05-28T08:30:10+01:00 0.5 https://www.iconplc.com/solutions/technologies/sims 2025-12-05T11:14:24+00:00 0.5 https://www.iconplc.com/solutions/real-world-intelligence/symphony-health/health-technology-and-business-intelligence-solutions 2025-06-02T11:49:26+01:00 0.5 https://www.iconplc.com/solutions/real-world-intelligence/symphony-health 2026-04-01T10:12:39+01:00 0.5 https://www.iconplc.com/solutions/real-world-intelligence/symphony-health/integrated-dataverse-and-source-solutions 2025-08-06T15:54:20+01:00 0.5 https://www.iconplc.com/solutions/technologies/symphony-health/optimise-brand-strategy-and-sales-effectiveness/health-rankings 2026-01-12T12:40:04+00:00 0.5 https://www.iconplc.com/solutions/real-world-intelligence/symphony-health/optimise-brand-strategy-and-sales-effectiveness 2025-06-02T11:49:46+01:00 0.5 https://www.iconplc.com/solutions/real-world-intelligence/symphony-health/solve-market-access-challenges 2025-06-02T11:50:12+01:00 0.5 https://www.iconplc.com/solutions/real-world-intelligence/symphony-health/understand-the-patient-journey 2025-06-02T11:50:52+01:00 0.5 https://www.iconplc.com/therapeutics/arrange-a-meeting 2026-03-03T13:14:18+00:00 0.5 https://www.iconplc.com/therapeutics/cardiovascular 2026-02-25T09:34:31+00:00 0.5 https://www.iconplc.com/therapeutics/cell-and-gene-therapies 2026-03-18T13:10:14+00:00 0.5 https://www.iconplc.com/therapeutics/central-nervous-system/cns-neurology 2026-03-18T13:05:28+00:00 0.5 https://www.iconplc.com/therapeutics/central-nervous-system/cns-pain 2026-03-04T11:46:20+00:00 0.5 https://www.iconplc.com/therapeutics/central-nervous-system/cns-psychiatry 2025-12-09T10:16:44+00:00 0.5 https://www.iconplc.com/therapeutics/central-nervous-system 2026-03-04T10:22:59+00:00 0.5 https://www.iconplc.com/therapeutics/endocrine-metabolic-disorders 2026-03-04T14:44:12+00:00 0.5 https://www.iconplc.com/therapeutics/hepatology 2026-03-03T15:13:30+00:00 0.5 https://www.iconplc.com/therapeutics 2026-03-10T14:31:22+00:00 0.5 https://www.iconplc.com/therapeutics/infectious-diseases 2026-02-04T12:16:00+00:00 0.5 https://www.iconplc.com/therapeutics/internal-medicine-and-immunology/dermatology 2026-03-09T13:49:33+00:00 0.5 https://www.iconplc.com/therapeutics/internal-medicine-immunology/gastrointestinal 2026-03-02T16:08:27+00:00 0.5 https://www.iconplc.com/therapeutics/internal-medicine-and-immunology/gastrointestinal/inflammatory-bowel-disease 2026-03-09T13:59:38+00:00 0.5 https://www.iconplc.com/therapeutics/internal-medicine-immunology 2026-03-09T14:05:06+00:00 0.5 https://www.iconplc.com/therapeutics/internal-medicine-immunology/ophthalmology 2026-03-20T10:54:39+00:00 0.5 https://www.iconplc.com/therapeutics/internal-medicine-immunology/respiratory 2026-03-09T14:18:33+00:00 0.5 https://www.iconplc.com/therapeutics/internal-medicine-immunology/rheumatology 2026-03-09T14:23:43+00:00 0.5 https://www.iconplc.com/therapeutics/internal-medicine-and-immunology/urology 2026-01-23T12:20:22+00:00 0.5 https://www.iconplc.com/therapeutics/medical-device 2026-03-10T14:29:31+00:00 0.5 https://www.iconplc.com/therapeutics/oncology/early-phase-oncology 2026-03-11T08:53:27+00:00 0.5 https://www.iconplc.com/therapeutics/oncology/immuno-oncology 2026-03-11T08:51:10+00:00 0.5 https://www.iconplc.com/therapeutics/oncology 2026-03-09T15:06:18+00:00 0.5 https://www.iconplc.com/therapeutics/pediatrics 2026-03-09T15:25:37+00:00 0.5 https://www.iconplc.com/therapeutics/rare-orphan-diseases 2026-03-11T18:16:42+00:00 0.5 https://www.iconplc.com/therapeutics/internal-medicine-immunology/transplant-immunology 2026-03-23T07:14:03+00:00 0.5 https://www.iconplc.com/therapeutics/vaccines 2026-03-26T12:29:21+00:00 0.5 https://www.iconplc.com/therapeutics/womens-health 2026-03-12T11:23:37+00:00 0.5 https://www.iconplc.com/news-events/events 2026-02-25T17:24:29+00:00 0.5 https://www.iconplc.com/news-events/events/industry-events 2026-03-11T12:01:49+00:00 0.5 https://www.iconplc.com/news-events/events/webinars 2026-03-12T11:19:52+00:00 0.5 https://www.iconplc.com/news-events/events/workshops 2026-03-12T11:51:42+00:00 0.5 https://www.iconplc.com/insights/blog 2026-02-09T09:11:33+00:00 0.5 https://www.iconplc.com/insights/transforming-trials/accelerating-biotech-innovation 2026-03-10T11:07:20+00:00 0.5 https://www.iconplc.com/news-events/thought-leadership 2026-03-24T15:50:07+00:00 0.5 https://www.iconplc.com/insights/transforming-trials/linguistic-validation-of-clinical-outcomes-assessments 2024-04-16T09:22:25+01:00 0.5 https://www.iconplc.com/insights/therapeutics/rare-and-orphan-diseases/pushing-boundaries-idiopathic-pulmonary 2024-04-24T12:05:12+01:00 0.5 https://www.iconplc.com/therapeutics/obesity 2026-03-13T07:05:54+00:00 0.5 https://www.iconplc.com/insights/transforming-trials/optimising-biotech-funding 2026-03-11T13:56:36+00:00 0.5 https://www.iconplc.com/search 2026-02-04T15:24:35+00:00 0.5 https://www.iconplc.com/solutions/laboratories/global-central-laboratories/laboratory-client-services 2026-03-19T15:07:57+00:00 0.5 https://www.iconplc.com/solutions/laboratories/global-central-laboratories/study-management-tools 2025-04-28T10:52:10+01:00 0.5 https://www.iconplc.com/insights/therapeutics/endocrine-and-metabolic-disorders 2026-03-10T15:53:00+00:00 0.5 https://www.iconplc.com/node/39071 2023-11-15T16:10:10+00:00 0.5 https://www.iconplc.com/solutions/laboratories/global-central-laboratories/laboratory-client-services/site-support-services 2025-12-02T16:54:44+00:00 0.5 https://www.iconplc.com/insights/therapeutics/womens-health-insights 2026-03-12T11:47:16+00:00 0.5 https://www.iconplc.com/solutions/outcome-measures/digital-health-technologies 2026-02-23T11:42:39+00:00 0.5 https://www.iconplc.com/insights/transforming-trials/ensuring-validity-clinical-outcomes-assessment-coa-data-value-rater 2024-04-15T15:03:37+01:00 0.5 https://www.iconplc.com/solutions/technologies/labview360 2026-03-11T12:09:12+00:00 0.5 https://www.iconplc.com/insights/therapeutics/public-health 2026-03-05T11:59:53+00:00 0.5 https://www.iconplc.com/insights/value-based-healthcare/strategies-commercialising-oncology-treatments-young-adults 2024-07-18T13:16:26+01:00 0.5 https://www.iconplc.com/about-icon/icon-asia-pacific/india 2026-01-29T16:49:14+00:00 0.5 https://www.iconplc.com/insights/digital-disruption/triad-trust-navigating-real-world-healthcare-data-integration 2025-05-08T13:31:33+01:00 0.5 https://www.iconplc.com/solutions/blended-solutions 2026-03-10T12:07:50+00:00 0.5 https://www.iconplc.com/insights/digital-disruption/ai-insights/applying-ai-manage-risks-and-costs-postmarketing 2025-08-12T10:20:28+01:00 0.5 https://www.iconplc.com/about-icon/icon-asia-pacific/china 2026-04-02T14:47:37+01:00 0.5 https://www.iconplc.com/solutions/laboratories/specialty-laboratories/molecular-pathology 2025-12-09T10:11:49+00:00 0.5 https://www.iconplc.com/solutions/laboratories/specialty-laboratories/genomics 2026-03-11T11:38:05+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies 2026-03-24T13:15:46+00:00 0.5 https://www.iconplc.com/privacy/potential-research-participants-and-general-website-users/dutch 2025-12-10T15:18:03+00:00 0.5 https://www.iconplc.com/privacy/potential-research-participants-and-general-website-users/german 2025-12-10T15:17:41+00:00 0.5 https://www.iconplc.com/privacy/potential-research-participants-and-general-website-users/hungarian 2025-12-10T15:17:16+00:00 0.5 https://www.iconplc.com/privacy/potential-research-participants-and-general-website-users/spanish 2025-12-10T15:16:46+00:00 0.5 https://www.iconplc.com/solutions/consulting/regulatory-affairs/project-services 2026-03-20T11:37:03+00:00 0.5 https://www.iconplc.com/insights/therapeutics/respiratory 2026-03-11T14:25:18+00:00 0.5 https://www.iconplc.com/solutions/clinical-scientific-operations/pharmacovigilance/risk-management-rems-solutions 2026-03-11T14:27:29+00:00 0.5 https://www.iconplc.com/solutions/regulatory-affairs/global-labelling-and-ad-promotion 2026-03-11T11:43:45+00:00 0.5 https://www.iconplc.com/solutions/consulting/regulatory-affairs/regulatory-operations 2025-12-12T17:07:58+00:00 0.5 https://www.iconplc.com/solutions/early-clinical/early-phase-obesity-trials 2026-03-10T15:34:44+00:00 0.5 https://www.iconplc.com/insights/therapeutics/oncology/icon-survey-report-innovation-oncology 2024-09-12T12:03:26+01:00 0.5 https://www.iconplc.com/insights/therapeutics/oncology/de-risking-clinical-development-precision-medicines 2024-10-03T14:05:02+01:00 0.5 https://www.iconplc.com/solutions/symphony-health-data/symphony-health-conference-posters 2025-12-08T10:51:27+00:00 0.5 https://www.iconplc.com/solutions/outcome-measures 2026-02-23T11:35:53+00:00 0.5 https://www.iconplc.com/about/icon-glance 2026-03-31T13:55:40+01:00 0.5 https://www.iconplc.com/solutions/laboratories/central-laboratory-solutions-biotech 2026-03-10T11:48:50+00:00 0.5 https://www.iconplc.com/insights/therapeutics/rare-and-orphan-diseases/therapeutic-spotlight-precision-medicine 2024-09-18T08:41:56+01:00 0.5 https://www.iconplc.com/insights/transforming-trials/blended-solutions-insights/embracing-blended-operating-model 2026-01-08T10:13:26+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/cardiac-safety-case-studies 2026-01-05T10:43:56+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/commercial-positioning-case-studies 2026-03-10T12:21:11+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/regulatory-affairs-case-studies 2026-03-24T13:20:49+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/dct-case-studies 2026-03-10T12:33:11+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/early-clinical-case-studies 2026-01-05T10:51:51+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/clinical-scientific-operations-case-studies 2026-01-05T10:46:29+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/medical-imaging-case-studies 2026-01-05T10:55:02+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/site-patient-solutions-case-studies 2026-01-05T11:18:59+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/strategic-solutions-case-studies 2026-01-05T11:30:23+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/therapeutics-case-studies 2026-03-12T11:05:39+00:00 0.5 https://www.iconplc.com/insights/therapeutics/oncology/advances-imaging-biomarkers-estimating-drug-efficacy-tumour 2024-10-21T12:53:07+01:00 0.5 https://www.iconplc.com/insights/regulatory-intelligence/demystifying-eu-ctr-mdr-and-ivdr 2024-11-20T10:19:37+00:00 0.5 https://www.iconplc.com/solutions/site-and-patient-solutions/sites 2025-08-05T09:22:29+01:00 0.5 https://www.iconplc.com/insights/digital-disruption/software-medical-device-samd/clinical-strategies-optimise-samd-treating-mental-health 2025-08-12T10:59:16+01:00 0.5 https://www.iconplc.com/about-icon/investigators/investigator-site-resource-centre/labview360 2026-02-20T16:26:08+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/biotech-case-studies 2026-03-10T11:44:17+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/asset-development-case-studies 2026-01-08T10:14:47+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/partnerships-case-studies 2026-03-11T14:07:52+00:00 0.5 https://www.iconplc.com/insights/digital-disruption/digital-disruption-surveying-industry-landscape 2026-03-10T14:25:11+00:00 0.5 https://www.iconplc.com/sectors/biotech/early-phase-challenges-biotechs 2026-03-10T15:26:34+00:00 0.5 https://www.iconplc.com/solutions/clinical-scientific-operations/pharmacovigilance/tailored-pharmacovigilance-solutions 2026-03-12T11:01:01+00:00 0.5 https://www.iconplc.com/sectors/biotech/early-phase-development-understanding-key-obstacles-biotechs-2024 2026-03-10T15:30:30+00:00 0.5 https://www.iconplc.com/solutions/technologies/ai 2026-03-10T11:22:43+00:00 0.5 https://www.iconplc.com/solutions/clinical-scientific-operations/pharmacovigilance/safety-reporting-group 2025-12-10T16:00:04+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/blended-solutions-case-studies 2026-03-10T12:09:03+00:00 0.5 https://www.iconplc.com/therapeutics/biosimilars/clinical-trial-development-planning 2025-12-09T10:13:21+00:00 0.5 https://www.iconplc.com/insights/therapeutics/central-nervous-system/advancing-alzheimers-parkinsons-rnd 2025-01-14T10:01:52+00:00 0.5 https://www.iconplc.com/solutions/regulatory-affairs/clinical-diagnostics-regulatory-affairs-ivdcdx 2026-03-10T12:19:13+00:00 0.5 https://www.iconplc.com/sectors/biotech/advancing-alzheimers-and-parkinsons-RandD 2026-03-11T13:38:27+00:00 0.5 https://www.iconplc.com/careers/bioanalysis-careers 2025-12-01T14:09:30+00:00 0.5 https://www.iconplc.com/solutions/site-patient-solutions/sites/icons-elite-sites-program 2025-12-09T10:05:19+00:00 0.5 https://www.iconplc.com/insights/regulatory-intelligence/exploring-fda-guidance-modern-data-monitoring-committees 2025-02-06T15:42:55+00:00 0.5 https://www.iconplc.com/insights/therapeutics/central-nervous-system/icon-survey-report-cns-therapeutic 2025-12-08T10:46:26+00:00 0.5 https://www.iconplc.com/sectors/biotech/icon-survey-report-cns-therapeutic-development 2025-02-20T08:49:45+00:00 0.5 https://www.iconplc.com/solutions/technologies/horizon 2026-03-11T11:51:50+00:00 0.5 https://www.iconplc.com/insights/digital-disruption/ai-insights/ai-and-clinical-trials/integrating-ai-clinical-research 2025-07-17T11:32:04+01:00 0.5 https://www.iconplc.com/insights/regulatory-intelligence/streamlining-dossier-preparation 2025-09-15T12:42:27+01:00 0.5 https://www.iconplc.com/solutions/clinical-scientific-operations/data-monitoring-committee-services 2025-12-15T12:13:19+00:00 0.5 https://www.iconplc.com/solutions/laboratories/bioanalytical-laboratories/adcs 2025-09-01T14:27:24+01:00 0.5 https://www.iconplc.com/solutions/laboratories/bioanalytical-laboratories/immunogenicty 2025-09-01T14:29:53+01:00 0.5 https://www.iconplc.com/contact/survey-thank-you 2025-12-01T14:23:22+00:00 0.5 https://www.iconplc.com/solutions/consulting/commercial-positioning-consulting/global-medical-and-commercial-agency 2025-12-09T10:14:49+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/laboratories-case-studies 2026-01-05T10:53:39+00:00 0.5 https://www.iconplc.com/solutions/laboratories/specialty-laboratories/laboratory-facilities/laboratory-facilities 2025-04-28T10:53:40+01:00 0.5 https://www.iconplc.com/insights/therapeutics/obesity/obesity-and-beyond-embracing-multi-indication-potential-during-clinical 2026-03-11T13:50:44+00:00 0.5 https://www.iconplc.com/insights/therapeutics/obesity/survey-report-how-todays-obesity-developers-are-navigating 2026-03-12T10:57:21+00:00 0.5 https://www.iconplc.com/insights/patient-centricity/prioritising-patient-centred-research-regulatory-approval 2025-07-17T11:32:33+01:00 0.5 https://www.iconplc.com/news-events/awards 2026-01-06T12:36:31+00:00 0.5 https://www.iconplc.com/solutions/site-and-patient-solutions/site-patient-obesity-solutions 2026-03-11T14:32:54+00:00 0.5 https://www.iconplc.com/solutions/technologies/smartdraft 2026-03-12T10:33:06+00:00 0.5 https://www.iconplc.com/insights/transforming-trials/blended-solutions-insights/observations-outsourcing-survey-results 2025-07-17T11:29:02+01:00 0.5 https://www.iconplc.com/solutions/clinical-scientific-operations/pharmacovigilance/safety-writing-solutions 2026-03-11T14:29:00+00:00 0.5 https://www.iconplc.com/solutions/symphony-health-data/making-medicines-more-affordable 2025-06-11T09:28:08+01:00 0.5 https://www.iconplc.com/insights/value-based-healthcare/integratedclaims 2025-12-09T10:04:45+00:00 0.5 https://www.iconplc.com/insights/digital-disruption/software-medical-device-samd/decoding-ai 2025-12-09T10:00:47+00:00 0.5 https://www.iconplc.com/solutions/laboratories/specialty-laboratories/laboratory-facilities/cambridge-specialty-lab 2025-05-30T15:16:51+01:00 0.5 https://www.iconplc.com/insights/digital-disruption/software-medical-device-samd 2026-02-10T13:52:05+00:00 0.5 https://www.iconplc.com/insights/therapeutics/oncology/future-oncology-biosimilars 2026-03-12T11:03:28+00:00 0.5 https://www.iconplc.com/sectors/biotech/behind-biotech-stories-science-and-resilience 2026-03-10T11:40:46+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/medical-device-diagnostics-research-case-studies 2026-03-11T13:33:57+00:00 0.5 https://www.iconplc.com/insights/transforming-trials/demystifying-systematic-literature-reviews 2025-08-13T14:28:44+01:00 0.5 https://www.iconplc.com/solutions/early-clinical/ethnic-bridging 2025-12-08T14:07:56+00:00 0.5 https://www.iconplc.com/solutions/early-clinical/medical-affairs 2025-08-20T17:51:22+01:00 0.5 https://www.iconplc.com/solutions/all-case-studies/real-world-dataevidence-case-studies 2026-03-11T14:16:16+00:00 0.5 https://www.iconplc.com/insights/regulatory-intelligence/accelerating-access 2025-09-01T14:16:06+01:00 0.5 https://www.iconplc.com/insights/regulatory-intelligence/navigating-regulatory-landscape-us-and-japan 2025-12-01T16:53:49+00:00 0.5 https://www.iconplc.com/insights/regulatory-intelligence/preparing-ich-gcp-e6r3-implementation 2025-10-03T13:58:14+01:00 0.5 https://www.iconplc.com/insights/regulatory-intelligence/meeting-requirements-joint-clinical-assessments 2025-10-22T06:53:20+01:00 0.5 https://www.iconplc.com/solutions/laboratories/specialty-laboratories/multiplex-immunofluorescence 2025-12-09T10:12:32+00:00 0.5 https://www.iconplc.com/solutions/laboratories/bioanalytical-laboratories/applications/pharmacokinetics 2025-09-02T13:08:09+01:00 0.5 https://www.iconplc.com/solutions/laboratories/bioanalytical-laboratories/applications/oligonucleotides 2025-12-01T17:04:25+00:00 0.5 https://www.iconplc.com/insights/therapeutics/biosimilars 2026-03-23T15:39:41+00:00 0.5 https://www.iconplc.com/solutions/all-case-studies/apac-case-studies 2026-03-10T11:25:11+00:00 0.5 https://www.iconplc.com/solutions/technologies/card 2025-12-08T10:40:24+00:00 0.5 https://www.iconplc.com/solutions/laboratories/bioanalytical-laboratories/applications/adme 2026-01-20T12:27:36+00:00 0.5 https://www.iconplc.com/solutions/laboratories/bioanalytical-laboratories/metabolites 2026-02-23T11:04:49+00:00 0.5 https://www.iconplc.com/solutions/laboratories/bioanalytical-laboratories/technologies/liquid-scintillation-counting-lsc 2026-02-23T11:19:24+00:00 0.5 https://www.iconplc.com/solutions/real-world-intelligence/symphony-health/health-technology-and-business-intelligence-solutions/metys 2025-12-08T10:41:49+00:00 0.5 https://www.iconplc.com/insights/patient-centricity/accelerating-clinical-development-through-dhts 2025-10-28T10:19:05+00:00 0.5 https://www.iconplc.com/insights/transforming-trials/more-monitoring 2025-12-24T08:50:08+00:00 0.5 https://www.iconplc.com/brazil-pay-transparency-reports 2025-10-02T13:12:19+01:00 0.5 https://www.iconplc.com/solutions/site-patient-solutions/patient-centred-services/site-engagement 2026-02-10T09:56:49+00:00 0.5 https://www.iconplc.com/solutions/site-patient-solutions/patient-centred-services/accellacare-site-resourcing 2026-03-26T12:24:29+00:00 0.5 https://www.iconplc.com/insights/therapeutics/infectious-diseases/optimising-vaccine-follow-through-early 2026-01-26T12:51:23+00:00 0.5 https://www.iconplc.com/solutions/medical-imaging/imaging-therapeutic-expertise/metabolic-disease 2026-02-23T11:26:18+00:00 0.5 https://www.iconplc.com/solutions/medical-imaging/imaging-therapeutic-expertise/metabolic-disease/obesity-weight-loss 2026-02-23T11:29:56+00:00 0.5 https://www.iconplc.com/solutions/technologies/firecrest/icon-swim 2026-03-05T09:17:18+00:00 0.5 https://www.iconplc.com/insights/digital-disruption/software-medical-device-samd/developing-ai-in-samd 2025-12-02T12:47:40+00:00 0.5 https://www.iconplc.com/insights/transforming-trials/bottlenecks-breakthroughs 2026-02-12T18:07:40+00:00 0.5 https://www.iconplc.com/sectors/biotech/2025-biotech-survey-report 2026-03-10T10:54:40+00:00 0.5 https://www.iconplc.com/sectors/biotech/2025-global-biotech-survey-report 2026-03-10T11:03:04+00:00 0.5 https://www.iconplc.com/sectors/biotech/2025-china-biotech-survey-report 2026-03-10T10:57:30+00:00 0.5 https://www.iconplc.com/solutions/clinical-scientific-operations/pharmacovigilance/post-marketing-pharmacovigilance 2026-04-01T13:01:02+01:00 0.5 https://www.iconplc.com/solutions/technologies/ai-icon/engageai 2026-01-15T13:44:44+00:00 0.5 https://www.iconplc.com/insights/value-based-healthcare/building-comparative-evidence-base-using-network-meta-analysis 2026-03-11T08:21:55+00:00 0.5 https://www.iconplc.com/insights/therapeutics/biosimilars/making-sense-rapidly-changing-biosimilars-landscape 2026-03-23T09:45:07+00:00 0.5 https://www.iconplc.com/solutions/consulting/externalised-development 2026-03-10T07:10:10+00:00 0.5 https://www.iconplc.com/insights/therapeutics/cardiovascular/test-ti-page 2026-04-01T09:43:22+01:00 0.5